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S U M M A R Y 
Allergic diseases such as allergic rhinitis and asthma are prevalent and have 
been increasing worldwide. The former is probably the commonest health 
problem amongst children and young adults. A recent (1955) international 
survey (ISAAC) documented 45% current rhinitis in Hong Kong teenagers. 
To study the aetiology of allergic rhinitis in Hong Kong we measured，in 57 
patients and the same number of sex- and age-matched controls, serum total 
IgE (Abbott DVLx™ analyser), mixed aeroallergen IgE (Phadiatop™), and 
specific IgE vs house dust mite {Der p I)，cockroach, cat and dog dander, 
mould mixture, and 4 local grass/weed pollens (Pharmacia CAP System™). 
Analytical performance of our newly purchased CAP System was first 
evaluated. This semi-automatic specific IgE analyser utilises allergen-
coupled reagent cups (LnmunoCAP) for fluorescence enzyme immunoassay 
performed on microtiter plates. Within- and between- batch precision (CV， 
n 二 20) ranged from 5.1 to 9.1% at low, medium and high specific IgE 
concentrations (1.92, 8.09/9.27，and 25.6/30.9 kUyO.). The assay was linear 
from 0.35 to 100 kU/L with a detection limit set at 0.35 kJJ/L. Recovery of 
spiked IgE ranged from 91 - 98%. Over a 6-month monitoring period, our 
assay was generally accurate with a slight bias from EQA consensus values 
up to -0.9 SD index units. The analysers was satisfactorily commissioned 
for routine service and research use. 
• 
ix 
Compared with sex- and age- matched controls, allergic rhinitis patients 
(26M, 31F; age 25 士11 years，range 10 - 62) had significantly elevated 
serum total IgE concentration (mean 士 SEM: 496 士 88 vs 179 士 38 kUyOL) 
and increased proportion of positive Phadiatop (95 vs 33%) and specific IgE 
j tests vs house dust mite (90 vs 44%) and cockroach (42 vs 9%, Mann-
Whitney and X2 tests, all p<0.005). Of the 54 patients with positive 
Phadiatop test, 47 (87%) had multiple allergy with positive specific IgE test 
to at least 2 aeroallergens and most (46) were sensitised to house dust mite. 
Four (7.4%) patients presented with single allergy exclusively to house dust 
mite. There was no significant difference between patients and controls in 
sensitisation to other allergen tested. 
I 
I 
House dust mite and cockroach ajre ubiquitous in Hong Kong. Their 
identification as aetiological agents of allergic rhinitis should help the 
development of strategies for reducing the inhalent allergen load to prevent 
and control this prevalent and costly disorder in our community. 
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1.1 Terminology and Overview 
ALLERGIC RHINITIS is an inflammation of the nasal mucosa (rhinitis) 
with an aetiology of allergen exposure and sensitization evidenced by 
medical history, physical examination, and/or laboratory tests [1]. 
Its clinical manifestations usually comprise frequent sneezing, clear 
rhinorrhoea, and nasal puritis progressing to congestion and obstruction. 
I It is a form of ALLERGY which has an original meaning, as pioneered by 
Clemens von Pirquet in 1906，of "altered reactivity" to a foreign substance 
I (allergen) after prior exposure [2 . 
With subsequent expansion of this concept by Gell and Coombs, allergy is 
now often used interchangeably with HYPERSENSITIVITY, which 
I denotes an abnormal and varied reaction following contact with substances 
that do not cause symptoms in other individuals [3'. 
The term ATOPY is also frequently used in reference to allergic diseases. 
Derived from the Greek word meaning "strange illness", it was introduced by 
Coca and Cooke in 1923 to describe allergic diseases that appear to have a 
genetic or familial basis [4]. Many allergists therefore use "atopic" instead 
of "allergic" to identify families and patients with predisposition to asthma, 
allergic rhinitis, and infantile eczema. 
Allergic diseases are prevalent (eg, 20-45% population has current rhinitis) 
[5]，costly (1990 US expenditure related to asthma = US$ 6.2 million) [6]， 
2 
and increasing worldwide [7，8]. Over the past 25 years rapid progress has 
been made in understanding the pathogenesis of allergic manifestations. 
I This include the structure and properties of IgE and FCg receptors, nature and 
composition of allergens, genetic and immunological control of IgE 
production and effector cell activation, and action of mediators on tissues, 
I which are outlined below (Sections 1.2 to 1.7). 
The remainder of this thesis describes approach and instrumentation for 
laboratory diagnosis and monitoring of IgE-medicated allergy, and reports 
on a study of the aetiology of allergic rhinitis in Hong Kong which was my 
chosen MSc project. 
1.2 Gell & Coombs Classification of Hypersensitivity 
When an individual has been immunologically primed/sensitised to an 
antigen/allergen, subsequent contact/exposure wil l result in secondary 
enhancement of the immune response. Such boosted reaction may be 
excessive causing gross tissue damage i f the antigeny'allergen is present in 
relatively large amounts, or the humoral and cellular immune states are 
already heightened. Manifestations of hypersensitivity are dependent on 
many variables which include the genetic constitution of the sensitized 
individual, the nature of the antigen/allergen involved, the route of its 
administration, the biological effects of the antibodies on sensitized cells, 
and local tissue response to the mediators. 
3 
Gell and Coombs devised a classification of hypersensitivity based on 
clinical manifestation, immunopathological mechanism and tissue effects 
into four types: Type I (immediate or anaphylactic), Type H (cytotoxic or 
cytolytic), Type HI (antigen-antibody complex or Arthus), and Type FV 
(delayed or cell-mediated) as schematically illustrated in Fig. 1.1. 
L 2.1 Type I - Immediate Hypersensitivity 
This hypersensitivity reaction usually develops within minutes after 
exposure to the allergen. Mast cells or peripheral blood basophils are 
sensitized by IgE antibodies which are synthesised by plasma cells upon 
appropriate allergenic stimulation. The binding ofIgE to mast cells involves 
the Fc portion of the IgE molecule and a receptor on the cell surface. 
Allergen from subsequent exposure cross-links cell-bound IgE, inducing 
degranulation of mast cells with release of inflammatory mediators (see 
Section 1.5) that are responsible for the wheal-and-flare skin reaction and 
other manifestations. Allergic rhinitis is mediated by Type I 
hypersensitivity. 
1.2.2 Type II - Antibody Dependent Cytotoxic Hypersensitivity 
Li this allergic manifestation, circulating IgG and IgM antibodies react with 
antigens that may actually be portions of cells such as the erthyrocyte 
membrane, or with an unrelated antigen, eg, a drug that has become 























































































































































































































































































































































































































activated. Thus the cell that function as the antigen or carries the appropriate 
antigenic determinant is usually destroyed or altered, resulting in injury to 
the erthyrocytes, leukocytes, or platelets. Clinical examples of this type of 
reaction include autoimmune haemolytic anemia, transfusion reaction, 
drug-induced antibody dependent haemolytic anemia. 
\ 
L 2.3 Type III ‘ Immune-Complex Mediated Hypersensitivity 
Li this immunopathological reaction, serum IgG antibodies interact with the 
antigen forming circulating immune complexes which aggregate in and near 
blood vessels. These antigen-antibody complexes activate the complement 
system, and components C5, C6, C7 attract polymorphonuclear leukocytes 
to the reaction site. Phagocytosis of the complexes may lyse the leukocytes, 
with resultant release of enzymes and other mediators causing inflammation 
and tissue destruction. Clinical examples of the Type DI reaction include 
i serum sickness syndrome, acute poststreptococcal glomerulonephritis, and 
systemic lupus erthyematosis. 
1.2.4 Type IV- Cell-mediated (Delayed-Type) Hypersensitivity 
The pathophysiology of this delayed-type injury is dependent on sensitized 
small T lymphocytes. There is no apparent interaction of the antigen with 
humoral antibodies or complement, either at the cell membrane or in tissues. 
After challenge with an antigen, the cell-mediated immune reaction results in 
accumulation of mononuclear cells at the site of tissue injury within 24 to 48 
6 
hours. Activation of macrophages, local proliferation of mononuclear cells 
and release of biologically active molecules (lymphocytotoxins, migration 
inhibitory factors, etc) are important in the development of the delayed 
hypersensitivity. Cell-mediated delayed hypersensitivity represents the 
pathophysiological basis for contact dermatitis and organ transplant 
rejection, and is also responsible for the observed tissue damage and 

















Century. Early in the 20th Century, the potential harmful effects of 
immunity were identified. Li 1902, Richet and Portier described the 
development of anaphylaxis in dogs upon administration of sea anemone 
toxin. Subsequently the phenomenon was documented in humans after 
injection of horse serum for passive immunization against tetanus and 
dipheria [9]. Li 1906, Clemons von Priquet defined allergy as altered 
reactivity to a previously exposed foreign substance [9]. 
Through the now classic experiments ofPraunitz and Kustner in 1921 [9]，it 
was recognised that serum of allergic individuals contained a humoral factor 
i that caused specific allergic sensitivity in non-allergic individuals. The 
I method that Praunitz and Kttstner used and its variations, called P-K 
I reaction, remained the standard for measuring skin-sensitizing antibody over 
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i 
of patients with ragewood pollinosis [9]. Thereafter, the factor was called 
atopic reagin, reaginic antibody, or skin-sensitizing antibody. 
Several common properties of reagins were recognised. These included 
susceptibility to mild reduction and inactivation by heating at 56°C for > 30 
minutes. However, the biochemical nature of reaginic antibodies remained 
obscure. 
Li 1967 Ishizaka and Ishizaka [10] in the US isolated reagins from sera of 
ragewood sensitive individuals and found that the reaginic activity did not 
correspond to any of the then known immunoglobulin (antibody) classes: 
IgG，IgM, IgA and IgD; suggesting that a fifth class of immunoglobulin, 
which they designated IgE, was responsible. Shortly afterwards, Bennich 
and Johnansson [11] in Sweden discovered a new myeloma protein termed 
IgND, and found that elevated levels of IgND correlated with allergic 
disorders. Li 1969, colaborative studies between the two groups confirmed 
that IgND was indeed an IgE myeloma. Thus a new class of 
immunoglobulin, IgE, was identified and defined. 
鲁 
. 
1.4 The Clinical Biochemistry of IgE 
7.4.1 Structure and Properties 
The structure of IgE is compared with that of IgG in Fig. 12. As with other 
immunoglobulins, IgE is composed of two heavy chains and two light chains 
{K or X isotypes) containing variable (V) and constant (C) polypeptide 
domains of about 110 amino acid each. But the heavy chain oflgE，called 
s chain, has five domains including an additional Cjj4 region causing an 
increase in molecule weight of the immunoglobulin to 190,000 Da. 
Cleavage of IgE with papain under optimal condition yields two Fab 
fragments and a Fc fragment [12]. Two antigenic determinants (s^, 82) are 
found in the Fc fragment. Each Fab fragment is composed of a light chain 
and a portion of the heavy chain called the Fd fragment. It contains an 
allergen binding sites (Fig. 1.2). 
IgE is a glycoprotein, the carbohydrate content is about 12% and the 
oligosaccharide units appear to be exclusively associated with the s chain. 
The major properties ofIgE include its heat stability and its ability to bind to 
mast cells and basophils. The cell binding activity of IgE resides in the Fc 
portion of the molecule and by heating the immunoglobulin at 56。C for 0.5 
hour its skin sensitivity capacity is destroyed. However, the antigen-binding 
capacity, which resides in the Fab portion, is preserved. 
The structures of lgG1 and IgE 
IgE lgG1 w v 
”旧_丨〜2 4 h 
F c j { ^ jgCn3 j j 
； |i CH^  
heavy chain - , . . 5 4 domains 
molecular 
weight ^ ^ 146 000 
carbohydrate 12% 2-3% 
I half-life (serum) 2Vi days 21 days 
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Figure 1.2 Comparison of structure and properties of IgE and IgGl. (From 
Roitt I, Brostoff J, Male D, eds. Mmunology. 3rd ed. London : Mosby-Year 
Book Europe Ltd, 1993 : 19.3)" 
• 
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L4.2 The Fc^ Receptors 
Two types of receptors are found on cell surface. The FCgRi receptor is the 
high-affinity receptor found on mast cells and basophils. It has been 
observed that although the serum half-life ofIgE is only 2.5 days，mast cells 
may remained sensitized for weeks or months. This is due to the high 
affinity binding of IgE to the FCgRj receptor, thereby conferring protection 
from proteolysis by semm proteases. Molecular biology techniques have 
been used to clone the gene encoding the s chain ofhuman IgE [13]. Several 
recombinant fragments of the 8 chain have been used as a probe to realize 
the s chain site that bind FCgRi receptor [14]. This site has been found to be 
localized to the CH〗and CH3 heavy chain domains. On the other hand, the 
low affinity FCgR2 receptor has been found on B lymphocytes, 
monocytes/macrophages, platelets and eosinophils (Fig. 1.3). Binding of 
IgE to this receptor places IgE at the centre of activation of many important 
j effector cells [15]. The FCgR2 receptor is cleaved into soluble products that 
retain the ability to bind IgE, and thus shown to play a role in the regulation 
ofIgE synthesis. 
1.4.3 Production and Tissue Localization 
With normal environmental allergenic exposure, most IgE synthesis in man 
does not take place in the spleen or lymph nodes but rather in lymphoid 
tissues lining the respiratory and gastrointestinal tracts [16]. Lideed, the 
11 
« 
Fc receptors for IgE 
^ Fc^ 
I 
r \ � 一 � 1 lectin 
, I y^~<^ \ \ :、 ) -homology 
丨 C l a ^ ) ) ^ ¾ - > ^ 丫 4 - -
I ^ i / W ^ " ^ [ ^ 60H^ 
C ^ - - , . . ^ ^ /--V.._^., NH2 Aproteolytic 
^ ^ ( y/ ) , /cleavage 
i jSXi^M^ k 
^ ^ ^ ^ “ “ J ^ ^ ^ ^ ^ ^ cytoplasm 
I n5c ^ ^ > g ^ 、 
COOH H2N HOOC COOH 
Figure 1.3 Schematic models of Fcs receptors on cell surface. FccRl is 
found on mast cells and basophils, FqR^ is found on lymphocytes, monocytes 
and macrophages. (From Roitt I, Brostoff J, Male D, eds. Lnmunology. 3rd 
ed. London : Mosby-Year Book Europe Ltd, 1993 : 19.12). 
12 
highest concentration of IgE-forming plasma cells are found in the tonsils 
and adenoids [16]. However, the traffic of IgE molecules from areas of 
production to the tissues and the circulation has not been established, though 
the areas of production in the respiratory and intestinal mucosa are i \ 





1.4.4 Turnover in Blood and on Mast Cells 
h I 
;i 
Waldmann et al [18] studied the metabolic fate of IgE using radio-labelled 
|i 
:| tracers and estimated the mean total circulating IgE pool to be 3.3p,g/ kg/day 
with an intravascular survival of 2.3 days. On the contrary, the half-life of 
IgE in human skin is longer, approximately 14 days as determined by passive 
transfer studies [19]. The basophil and mast cell bound IgE pool has yet to be 
investigated. Direct quantitation of specific IgE in the blood as contrasted to 
specific IgE on the basophil surface indicated that for every IgE molecule on 
the basophil, there are 100 to 4,000 molecules in circulation [20]. 
！ 
1.4.5 Control of Synthesis 
The control of IgE synthesis is very complex, requiring not only T-helper 
(lH) and T-suppressor (Ts) cell control, but also depends on major 
histocompatibility complex restriction, expression of FCgR2 receptor, and the 
presence of monocytes and other cytokines [21, 22]. Subsets ofhelper cell 
(lH2) that produce particular profile of lympokines are responsible for the 
regulation ofIgE production by B lymphocytes, n,-4 released by TH2 cells 
13 
enhances IgE production, whereas ffNy from THl cells is inhibitory. It is 
noteworthy that Tm cells also produce U^-5, which promotes the synthesis 
and secretion of IgA from B cells and is crucial in stimulating eosinophil 
development and activation. The production of EL-4 and BL-5 by T m cells 
I explains the close association of eosinophils with IgE-mediated allergy. 
Clearly, influencing the profile of lymphokine production, or the effect of 
lymphokines, could be useful in treatment of IgE-mediated allergy. 
j 
i. 4.6 The Role ofIgE in Health and in Disease 
It has been shown that the foetus is capable of producing IgE by 11 weeks' 
gestation [23] and that matemal IgE does not cross the placenta. Li children, 
serum IgE concentration increases steadily, and peaks between 10 to 15 
years (Table 1.1). Thereafter the level declines with advancing age (Table 
1.2). Men generally have higher concentration than women. Several roles 
for the possible beneficial effects of IgE antibody have been postulated by 
various studies. It appears that IgE antibodies on the surface of mast cells in 
the gut may be responsible for triggering histamine release and reduce the 
worm burden [24]. Furthermore, IgE complexed to parasitic antigens has an 
important role in antigen-dependent cell-mediated cytotoxicity whereas 
eosinophils, macrophages and platelets are effector cells that cause damage 








Table 1.1 Serum total IgE concentrations in children. (Adapted from 
Kjellam N - M , Johnansson SGO, Roth A. Serum IgE levels in healthy 
children quantitated by sandwich technique (PRIST). Clin Allergy 1976; 
6:51) 
Age No Geometric mean 95the percentile limits 
concentration (ng IgE / ml) ^ 
(ng IgE / ml) a 
Cord blood 24 ^ 0.1-3.1 
6 weeks 17 1.67 0.2- 15 
3 months 15 1.98 0.4-9.1 
6 months 15 6.49 1.0-39 
9 months 16 5.71 1.8-18 
lyear 12 8.45 1.9 -37 
2years 18 7.33 0.8 -7.1 
3years 6 4.36 0.5 -41 
4years 7 20.8 2.6 - 167 
7years 18 31.2 2.5 -390 
10 years 17 57.3 2.4- 1381 
14 years 19 48.6 5.0 -472 
M k U / L = 2.4 ng /m l 








Table 12 Serum total IgE concentrations in adults. (From Yunginger JW. 
Diagnostic Testings, skin tests, total IgE levels, and specific IgE antibody 
levels, hi : Kaplan AP, ed. Allergy. New York : Churchill Livingstone, 
1985:pp217-232). 
Population Mean conc. Normal range 
I (RJ IgE/ml) 95the percentile limits 
(KJ IgE / ml) g 
Double-antibody RJA 
I Nonatopic adults (N = 95)" 74.6® 2.5 - 325 
I Nonatopic adults (N = 102)' 36.3。 1 -178 
Nonatopic adults (N = 73)。 43.8^ 2.1 - 852 
Solid-phase RL\ 
Swedish adults (N = 175)' 14® 1 -120 
I' a From ref. 25; ^ from ref. 74;。from ref. 84. 
1 ： 
1 
i d Quoted in Homburger HA, Yunginger JW : Laboratory testing in the 
i 
diagnosis and management of allergic diseases, p. 351. Li homburger HA, 
Batsakis JG (eds) : Clinical Laboratory Annual: 1983. Vol. 2 Appleton-
Century-Crofts, Norwalk，CT，1982. 
e Arithmetric mean. 
^Geometric mean. 
gKJ/ml = kU/mL. 
16 
.I 
On the other hand, serum total IgE concentration has been measured in a 
variety of disease states. Adults and children with allergic rhinitis and 
asthma, atopic dermatitis, eczema tend to have elevated serum IgE 
concentration. About 50% of such patients have concentrations that are 2 
standard deviations above the mean of age-matched controls. However, 
significant overlap of toal serum IgE concentration between normal subjects 
and patients has been demonstrated (Fig. 1.4). There are also many non-
allergic diseases which may be associated with elevations in serum total IgE 
(Table 1.3). Low levels of serum total IgE are frequently seen in 
immunodeficiency diseases such as hypogammaglobulinaemia or ataxia 
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Figure 1.4 Cumulative frequency graph showing serum total IgE 
concentrations in non allergic (•) and allergic ( • ) populations (solid lines), 
and the differences in cumulative frequency between the two populations 
(broken line). ^From Marsh DG，Bias WB, Ishizaki K : Genetic control of 
basal serum immunoglobulin E level and its effect on specific reagenic 
sensitivity. Proc Natl Acad Sci USA, 1974; 71 : 3588). 
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Table 1.3 Allergic and non-allergic diseases associated with elevated 
serum total IgE concentration. (Adapted from Kaplan AP，ed. Allergy. New 
York : Churchill Livingstone, 1985 : p.224). 
Allergic diseases Lnmunologic diseases 
Seasonal allergic rhinitis Job-Buckley syndrome 
extrinsic bronchial asthma selective IgA deficiency 
atopic dermatitis Wiskott-Aldrich syndrome 
Parasitic diseases thymic alymphoplasia 
ascariasis graft vs host disease 
capillariasis Cutaneous diseases 
fascioliasis chronic acral dermatitis 
I 
hookworm streptococcal erythema nodosum 




shistosomiasis Kawasaki's disease 
trichinosis infantile polyarteritis nodosa 
visceral larval migrans primary pulmonary hemosiderosis 
Lifections nephrotic syndrome 
allergic bronchopulmonary- bums 
aspergillosis Guillain - Barre syndrome 
systemic candidiasis malignant lymphogranulomatosis 
leprosy Hodgkin's disease 
Epstein-Barr virus mononucleosis 
Cytomegalovirus mononucleosis 
19 
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1,5 Pathophysiology of lgE-Mediated Hypersensitivity 
L 5.1 Cell Activation and IgE Synthesis 
The lymphoid system and its cellular components are essential to the 
synthesis of antibodies involved in allergic reaction. The cellular 
interactions by which allergen sensitisation results in the synthesis of 
allergen specific IgE antibodies (Fig. 1.5). Lmocuous environmental 
allergens enter via mucosal surfaces, and are taken up by local allergen-
processing cells (macrophages), which process and present them to TH cells, 
1 
and at the same time, synthesise D^-I. This lymphokine stimulates and 
activates the T-cells which begin producing D^-2, thereby stimulating the 
CD4 TH cells. The activated CD4 lymphocytes, via cell to cell interaction 
and release of cytokines, stimulate the bone marrow derived B lymphocytes 
to proliferate and differentiate into plasma cells that synthesise and secrete 
the specific IgE immunoglobulins. The interleukin IL-A plays a central role 
in the regulation of IgE synthesis which can be promoted by EL-5 and EL-6. 
Circulating IgE binds, via the FCg receptor (FCgRi) to mast cells thereby 
sensitising them. After sensitisation, T and B cells continue to co-operate in 
the regulation of immunoglobulin synthesis with the sub-population of CDs 
T cells functioning as suppressor cells which down-regulate antibody 
synthesis. Thus T cells and cytokines not only co-operate in the initiation of 
IgE antibody synthesis, they also regulate the synthesis through ^oth 
stimulation and suppression ofB cell function. It has also been shown that 
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Figure 1.5 The interaction oflymphoid cells and cytokines in IgE synthesis. 
(From Fireman P, Slavin RG, eds. Atlas of Allergies, Philadelphia : 
Lippincott, 1991 : 1.14). 






and DL-5 [22], and this may explain the eosinophilia that is so frequently 
associated with IgE mediated allergic diseases. 
1,5.2 Activation of Mast Cells and Basophils 
Mast cells and basophils possess about 50,000 to 500,000 high affinity intra 
membranous receptors (FCgR! ) specific for the Fc portion of the IgE 
molecule [27]. During the sensitisation period, there is no deleterious host 
reaction. However, on subsequent challenge, the cross linking or bridging of 
2 or more receptor-bound IgE molecules by allergen or other molecules such 
as lectins (PHA and Con-A which bind to the carbohydrate residue of Fc 
region) leads to aggregation of Fc receptors, resulting in cell activation and 
perburbation of the mast cell membrane，thereby triggering a calcium-ion 
influx which is essential to degranulation. This last process involves 
microtubule formation, movement of the granules to the cell membrane, 
fusion of the granule and plasma membrane, and finally release of preformed 
granule-associated mediators, k i addition, plasma membrane activation 
allows phospholipase h i to release arachidonic acid，giving rise to 
prostaglandins, thromboxane and leukotrienes. Thus combination of 
allergen and IgE antibody results in a sequence of energy- dependent enzyme 
reactions, with activation of the cell membrane that initiates the synthesis 
and release of specific pharmacological mediators. These mediators may be 
preformed and stored in mast cell granules or generated from phospholipids 
of the mast cell or basophil membrane. The preformed mediators include 
histamine and eosinophil chemotactic factor (ECF-A). While the newly 
synthesised mediators of anaphylaxis are metabolites of arachidonic acid 
22 
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such as prostaglandins of the cyclooxgenase pathway, and leukotrienes of 
the lipoxygenase pathway (Fig. 1.6). Both the preformed, granule-
associated lipid mediators and the newly-formed lipid mediators have the 
following main areas of action. 
Chemotactic Agents attract a variety of cells to the site of mast cell 
activation, in particular eosinophils, neutrophils and mononuclear cells 
including lymphocytes. Lti addition, recent evidence suggests that certain of 
the preformed cytokines released from degranulating mast cells are also 
chemotactic for inflammatory cells. 
Inflammatory Activators can cause vasodilation, oedema and via platelet 
activating factor (PAF), microthrombi, leading to local tissue damage. 
Tryptase, the major neutral protease of human lung mast cells can activate 
C3 directly, this function being inhibited by heparin. 
Kininogenases are also released and these affect small blood vessels by 
i • 
！ generating kinines from kininogens, again leading to inflammation. 
Spasmogens have a direct effect on bronchial smooth muscle, but can also 
increase mucus secretion leading to bronchial plugging. 
Once the leukocytes, mast cells, basophils, neutrophils and eosinophils are at 
the site of allergen challenge, a release of late-reaction medicators will 
occur. The leukocyte mediators include eosinophil cationic protein (ECP), 
eosinophil protein-X (major basic protein), eosinophil peroxidase and 
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Figure 1.6 Mast cell activation and release of pharmacological mediators. 
(From Fireman P, Slavin RG, eds. Atlas of Allergies, Philadelphia, 
Lippincott, 1991 : 1.23). . 
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j adding to the inflammatory state. Furthermore, the release of EL-4 from the 
mast cells contributes to the ongoing stimulation of a Tu2 lymphocyte 
response which, together with a cognate interaction with B cells, results in 
ftirther production of IgE antibodies by the plasma cells. Both these routes 
wil l contribute to the state of chronic allergic inflammation. 
1.6 Allergens 
Allergens are those antigens responsible for clinical allergic diseases. They 
are usually proteins or glycoproteins capable of inducing synthesis of IgE 
I antibodies, thereby sensitising the genetically predisposed person. Before an 
allergen can stimulate IgE production, it must gain access to sites patrolled 
by the immune system. Most allergens are able to cross mucous membrane 
!' following inhalation or ingestion; some gain access by direct contact or 
injection. 
Allergens can be classified on the basis of their nature or the manner to 
which the patient is exposed. Those responsible for allergic respiratory 
diseases，including allergic asthma, allergic rhinitis, are principally inhalent 
or aeroallergens, eg: pollens, dust mite, cockroach and animal dander. Foods 
such as egg, fish, milk, nuts, etc and other ingestants including drugs are 
important for allergic gastrointestinal and skin diseases. The contactants are 
principally responsible for allergic contact dermatitis. 
Though the precise composition of many of the allergens is still undefined, 




or glycoproteins with molecular weights that generally range from 10-40 
kDa. They are carried on particles that range in size from <5 ^im to >60(im 
(Table 1.4). For a particle to be clinically significant as an aeroallergen, it 
must be buoyant, present in significant concentrations and allergenic [28]. 
Particle size is also important too, as allergens carried on small particles wil l 
tend to remain airbome for a longer period of time and deseminate more 
widely (Table 1.5). 
Plant Pollens represent one ofthe most clinically important allergen sources 
and may account for 10-20% of allergic diseases in many communities, 
• 
usually presenting as seasonal rhinitis [29]. The major allergenic pollens are 
those derived from the wind-pollenated plants, and the pollens produced are 
p f 
characterised by their buoyant density, ease of dispersion and profusion [28]. 
Pollen grains range from 5 to >200 jiun in size, but among wind-bome' 
pollens the size range varies from 15-60 |im. The major allergens of many 
pollens, particularly rye grass, ragweed and birch tree, have been identified 
and characterised [30:. 
House Dust Mites of the genus Dermatophagoides (major species 
pteronyssinus and fairinae) are the most important indoor allergens. They 
are eight-legged animals that are toxonomically close to ticks and spiders. 
Mites grow best on beddings (eg, mattresses and pillows), stuffed toys and 
carpets in warm areas (20-30°C) with high humidity (60-80%) and feed on 
human skin scales [31]. They are ubiquitous and have been found in house 
dust samples in Europe, US, Australia, and Asia [32, 33, 34，35, 36, 37 . 
Major allergens, eg, Der p I (24 kDa) and Der p H (15 kDa), have been 
I i 
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Table 1.4 Allergen particle size and airway deposition. (Adapted from 
Robert A Wood. L i : Allergens. Allergic and Non-allergic Rhinitis, Clinical 
Aspects. MygindN. and Naclerio R, eds. Copenhagen, Munksgaard, 1993 
P.24). 
Particle size Percentage reaching lower air ways 
> l O u m 0% 
5 um 20% 
l - 2 u m 100% 
^ 
I Table 1.5 Allergen particle size and buoyancy. (Adapted from Robert A 
Wood. L i : Allergens. Allergic and Non-allergic Rhinitis, Clinical Aspects. 
Mygind N and Naclerio R, eds. Copenhagen, Munksgaard, 1993 : p.23). 
Particle source Size range (um) Persistance (still air) 
^ “ 0.05 - 20+ 6 min - 75 d a y s “ " • 
Dust mite 6+ < 36 min 
Pollens 10 - 100 9 sec - 13 min 
Tobacco smoke 0.01 - 1.0 19 X - 400 days 
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measured extensively. General agreement now exists regarding levels that 
are significant for risk of allergy [38，39]. 
Cockroaches have also been shown to be an important source of indoor 
allergen, particularly in inner city dwellings. Major allergens from both the 
I German {Bla g I and Bla g H) and American species have been identified and 
characterised. These allergens appear to be widely distributed with the 
highest levels in kitchens and other food storage areas [40]. 
Moulds grow best in warm areas with high humidity and their spores (<10 [• . 
^m ) are abundantly airbome and small enough to penetrate deep into the 
respiratory tract. Although there is a huge variety of indoor and outdoor 
fungi, relatively few are clinically important and among them include the 
Cladosporium, Penicillium, Altemaria and Asperigillus species [28, 4T. 
Major allergens have not been identified rendering preparation of reliable 
extracts for diagnostic and therapeutic uses difficult [42]. 
Animal Danders are another important aetiological agent of allergic 
rhinitis. This is because many are highly immunogenic and humans have 
close contact with them. Cat and dog allergens are commonly found in 
house dust, and rodents including guinea pig, hamsters, rabbits and mice are 
frequently kept as pets [42]. For example, Fel d I is produced predominately 
in cat saliva, and major dog allergens are present in saliva, dander and urine 
[42]. 
There is a wide spectrum of sensitivity to environmental allergens in any 




irrespective of the level and duration of exposure, to those who show 
I extensive sensitisation to low levels of multiple allergens. This atopic 
1 tendency，not only is genetically determined, but is also dose-dependent 
amongst predisposed individuals [43]. Thus, an initial and sufficient 
aeroallergen exposure to cause sensitisation followed by continuous 






i 1.7 Factors Predisposing to Allergy 
The clinical manifestation of allergic diseases are dependent on many 
variables, which include the genetic constitution of the sensitised individual, 
t 
！ the nature and route of administration ofthe allergen involved, the biologic 
|i 
properties ofthe antibodies and effector cells, and the local tissue response to 
effector cells and their mediators, hi general, risk factors predisposing to 
allergy are (1) genetic predisposition, (2) environmental exposure, and (3) 
underlying infection and immune status. 
1.7.1 Genetic Predisposition 
The familial nature of allergic diseases has been recognised for years, and a 
positive family history has been reported in 75% of allergic patients [44]. 
Retropective family studies suggest that when both parents are affected, 
allergic diseases is present in about 60% of the offsprings (Fig. 1.7). When 
only one parent is affected, about 30% of the children are allergic, ffboth 
parents are non-allergic, only 12% of the children are allergic [3]. There are 
2 main genetic mechanisms regulating the allergic response [45]. 
(1) Serum total IgE concentration. Families with at least one member 
having high concentration increases the likelihood of atopy [46]. 
(2) HLA-linked response. Specific antibody synthesis to a well-
characterised antigen is controlled, in part, by immune response (L:) genes 
linked to the major histocompatibility locus (HLA) [45]. There is a strong 
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Figure 1.7 Genetic predisposition of allergy. Left panel : the greater the 
parental history of allergic disease, the greater the risk of atopy in the 
offspring. Right panel : the concoidance of atopic disease in dizygote (Dz-
nonidentical) twins and monozygotic (Mz-identical) twins. (From Roitt I, 
Brostoff J, Male D, eds. Lmmunology. 3rded. London : Mosby-YearBook 
EuropeLtd, 1993 : 19.6). 





i association between HLA-B8 and HLA-DW2 and skin sensitivity to 
t,! 
common environmental allergens. Patients with HLA-B8 also have elevated 




L 7,2 Environmental Exposure 
Though the tendency of developing allergic disease is clearly familial, 
allergy is not entirely inherited, and the host response is dependent on 
appropriate environmental exposure [49]. Not only exposure to natural 
airbome allergens can lead to allergic disease, environmental pollutant such 
as sulphur dioxide, nitrogen dioxide, diesel exhaust particles may increase 
mucosal permeability and enhance allergen entry and IgE responsiveness, 
thereby contributing to the increase in allergic diseases. 
L 7,3 Underlying Infection and Immune Status 
There is evidence that viral infection can promote IgE response to allergens 
[50]. Viral infection not only decreases Ts cell activity but also exacerbate 
allergic symptoms by enhancing histamine and other mediator release. 
Additionally, vims can damage epithelial surfaces, thereby enhancing 
allergen entry. 
； 3 2 
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1.8 Epidemiology 
1,8.1 Allergic Diseases Worldwide 
Li the modem world, allergy is one of the commonest health problem 
affecting mankind. It is estimated that 10-20% of the population suffer from 
some kind of allergy [5]. There is also substantial evidence that the 
c 
incidence has been increasing [51, 52，53, 59]. t i the 1970s，American 
cumulative prevalence figures ranged from 9 to 21% for allergic rhinitis and 
4-8% for asthma [54,55]. Li 1990 data from the National Mstitute of Allergy 
and Lifectious Diseases showed that about one in every six Amercians had at 
least one kind of allergic disorder. The vast majority, more than 22 millions, 
suffered from hay fever or seasonal rhinitis, 10 millions had asthma and 
almost 12 millions were allergic to certain foods or drugs with atopic 
dermatitis [40]. Li Australia, asthma and allergic rhinitis in both adults and 
children have also been found to be increasing in recent years. Li a 4 year 
longitudinal study of children aged from 8 to 10 between 1982-86, Peat et al 
[32] found that wheezing increased from 10.5% to 14.9%，while other 
respiratory symptoms increased from 25.5% - 36.8%. A more extensive 
work done by the same investigators covering two decades from 1981 to 
1991 observed an increasing trend in hay fever (21.6% to 46.7%) and asthma 
prevalence (9% to 18%) [7]. This increase in prevalence of allergic 
disorders has occurred not only in Westem countries but also in Asia 
although they are generally less common. Li Papua New Guinea, a dramatic 
rise in asthma prevalence in both children and adults were noted between 
1974 and 1983 [33]. The prevalence ofhay fever was reported to be 15.7%, 
11.2% and 2.1% in Hong Kong, Malaysia and China, respectively [40]. 
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Also, hospital admission rate and mortality of asthma in both children and 
adults have shown a dramatic increase in recent years [52, 53]. Li US, the 
I cost of illness related to asthma was estimated to be US$ 6.2 billions while 
！ the loss of revenue due to reduced productivity and absence from school 
approached US$ 1.0 billion in 1990 [40]. ln 1991，asthma alone affected 
around 1.4 million Australians and resulted in a total cost expenditure of A$ 
585 to 720 millions [40]. Allergic diseases are therefore prevalent and very 
f 
[ costly health problems in the community. 
1,8.2 Allergic Diseases in Hong Kong 
Mormation on the prevalence of allergy and atopy in Hong Kong has been 
limited. Using questionnaire alone, Fung in 1982 reported that asthma and 
hay fever affected 3% and 2% respectively in Chinese subjects [56]. Data 
from Queen Mary Hospital in Hong Kong showed a dramatic five-fold 
increase in asthma admissions in children between 1974 and 1986 [40]. 
Recently in 1993, a more extensive study ofl062 school children aged 10 to 
20 years was conducted by Leung and Tseng using questionnaire and 
skinprick tests [40]. These authors reported that nearly 30% of children had 
some form of rhinitis symptoms with sneezing, nasal blockage and 
rhinorrhoea. Perennial rhinitis was the commonest allergic symptoms 
affecting 21.9% children studied. Seasonal allergic rhinitis, however, was 
less common, affecting 15.2% of the children. 
34 
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1 The prevalence of wheezing and asthma were found to be 8.6% and 7.2%， 
respectively. Slightly less than half of the children (44.5%) had at least one 
allergic symptom out of allergic rhinitis, eczema and asthma some time in 
the past, and 57.7% had more than one positive reactions for skin test. 
Among the atopic children the commonest aeroallergens that showed 
positive skin tests were dust mite (96.3%), cockroach (44.6%), and house 
i" 
f j' 
mould (40.6%). Allergy to pollens and animal allergens (cat and dog) were 




1.9 Diagnosis of IgE Mediated Allergy 
\ 
^ 
L 9.1 Medical History and Physical Examination 
The diagnosis of IgE-mediated allergy usually begins with a detailed and 
perceptive enquiry into the patient's medical history together with a thorough 
physical examination. As previously discussed, allergic diseases are 
influenced by genetic factors and allergen exposure. Therefore, all histories 
of allergy and related chronic inflammation both from patients and families 
are very important. Such information not only provides a useful assessment 
of the patient's general health, it also helps to prevent mis-diagnosis of 
allergy in non-allergic illness. Li addition, a discerning allergy history based 
especially on time, place and duration of symptoms can often give guidance 
to cause(s) of the patient's allergic problem before diagnostic tests are 
performed. Accordingly, objective information obtained from physical 
examination (eg: spirometry for asthma, rhinoscopy for rhinitis, etc), a 
carefully designed questionnaire, and relevant test results should be 
evaluated in comparison with the patient's subjective complaints. Once 
allergy is suspected, a final diagnosis must be confirmed by allergy tests to 
establish whether a patient's allergy is IgE-mediated, and i f so, to further 
identify the offending allergen(s). 
1,9,2 Introduction to Diagnostic Tests 
Diagnostic tests for suspected allergic disease may be conveniently divided 
into in vivo and in vitro categories, t i vivo tests include the direct skin test, 
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passive transfer skin test (P-K test), and various other mucosal provocation 
tests such as the inhalation challenge tests. Jn vitro diagnostic tests include 
the serum total IgE and allergen-specific IgE, leukocyte histamine release 
test, eosinophil cationic protein (ECP) and protein X (EPX) measurement, 
neutrophil myeloperoxidase (MPO) and mast cell tryptase assays [57，58]. 
1.9.3 Skin Tests 
Skin testing has remained the most commonly used diagnostic test for 
allergy. It involves delivering an extract of allergen(s) beneath the stratum 
comeum and barrier zone of the dermis and are of two types: the 
epicutaneous or prick method, and the intracutaneous or intradermal test. 
The former is easier and safer to perform, causes little discomfort, and 
positive results correlate with clinical symptoms. The latter is more 
reproducible and sensitive but associated with discomfort and increased risk 
of systemic reactions. 
Li both tests, when allergens combine with specific IgE fixed to mast cells in 
the skin, these cells are activated and release vasoactive mediators 
particularly histamine. Such reaction occurs within 10 minutes, peaks 
between 15-20 minutes and subsides. It is characterised by a typical wheal 
and flare reaction that is dependent on both the inflammatory and neurogenic 
mediators and is constantly followed by progressive infiltration of the dermis 
by eosinophils and neutorphils, leading to a late phase reaction of 




Thus the ability of a patient to develop an IgE-mediated response to allergens 
is a prerequisite for positive results in allergen skin tests. A grading system 
from 0 to 4+ (Fig. 1.8) has been devised according to the diameter ofboth the 
erthyma and the wheal. The advantages and disadvantages of the above two 
methods for skin tests still remain the subject of controversy. The 
intracutaneous test is more sensitive than the prick test as it allows titration, 
but the risk of systemic anaphylaxis is higher. On the other hand, the prick 
test is easier to perform and is more tolerable than the intracutaneous test, 
especially for children. 
There are several circumstances that may account for negative skin test 
results in a patient with IgE-mediated allergy. The most common causes are 
listed in Table 1.6. Conversely, several reasons may account for the 
situation when a skin test is positive in the face of a negative clinical picture 
(Table 1.7). Nevertheless, a carefully performed and correctly interpreted 
skin test with high quality allergen extracts and a battery that include all 
relevant allergens of the patient's geographic area is a simple, inexpensive lj 
ti 
i 
and useful diagnostic method. |j i 
I 
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L9A In Vitro Tests 
The discovery of IgE in 1967 [11] was a major breakthrough in the 
understanding and diagnosis of allergic diseases. Laboratory tests based on 
IgE assay have improved the diagnosis of allergic diseases in many 
circumstances and often made it possible to avoid performing bronchial or 
nasal challenge. Li vitro tests are based either on the measurement of serum 
38 
Commonly used scoring system for grading the response to 
Hypersensitivity Skin Test 
Grade Wheal Erythema 
0 (-) < 3 mm 0 - 5 mm 
1+ 3 - 5 mm 0 - 10 mm 
2 + 5 - 10 mm 5 - 10 mm 
3 + 10-15mm > 10 mm 
4 + > 15 mm >20 mm 
'1 i 
I 
. [i 'i |i 
Figure 1.8 Commonly used scoring system for grading the response to i 
I： 
hypersensitivity skin testing. (Adapted from Fireman P, Slavin RG, eds. ；' 
:^  








Table 1.6 Reasons for false negative skin test results. 
1. Poor quality antigen extracts 
2. Lnproper storage of antigens 
3. Miibitory drugs 
4. Lnproper administration skill 
5. Decrease skin reactivity in infants and elderly 
6. Disease attenuating skin tests 
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Table 1.7 Reasons for false positive skin test results. 
1. Lnproper preparation and administration of antigen extracts 
2. Non-specific irritant reaction 
3. Dermatographism 




total IgE concentration orthe detection/quantitation of allergen-specific IgE. 
1,9.5 Serum TotalIgEAssay 
(1) Test Principle 
The concentration of IgE in serum (p.g/L) is far lower than those of other 
immunoglobulins (IgG, IgA and IgM，g/L). toimunodiffiision, turbidi-
1 
metric and nephelometric techniques are not sufficiently sensitive to detect 
IgE in normal sera. Radio-isotope or enzyme immunoassays had to be 
developed. Total IgE assay is best performed using either a double antibody 
radioimmunoassay [60] or a solid-phase sandwich enzyme immunoassay 
[61]. 
Li a double antibody radioimmunoassay, IgE in patient samples and 
standards compete with a fixed amount of radio-labelled IgE for binding to 
anti-IgE antibodies. After incubation, bound IgE is precipitated by addition 
of a second antibody. Radioactivity in the pellet is measured in a gamma 
counter and is inversely proportional to test IgE concentration. IgE 
concentration as low as O.ljug/L can be measured by this method. 
The solid-phase sandwich assays utilize polyclonal anti-IgE antibody 
coupled covalently to a filter paper disc or cellulose cup, to which patient's 
serum or IgE standard is added. After incubation and washing steps, the 
bound IgE is detected by incubating the disc or reagent cup with radio or 
enzyme-labelled anti-IgE antibody. The radioactivity or enzyme activity 
41 
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measured on solid phase is directly proportional to the concentration of IgE 
in the test serum. 
I Most commercial reagents are standardised against a World Health 
Organisation Memational Reference Serum or the British Standard BS 
75/502 [62] and results reported in kU/L (1 kU = 2.4 ng). 
The early radioimmunosorbent test (RIST) in 1971 was the first 
I commercially available assay for total IgE [63]. However, the assay was not 
accurate for concentrations <100 kJJ/L, and it was subsequently replaced by 
the paper-disc radioimmunosorbent test (PRIST) in 1975 [64]. This method 
is a solid-phase sandwich radioimmunoassay (see above principle) which is 
very specific and sensitive with a detect limit down to 0.2 kUyT .^ 
Many other techniques for IgE quantitation have been developed, among 
them the fluorescence enzyme immunoassay is more widely used. Others 
such as magnetic enzyme immunoassay, a hemagglutination assay, the 
I 
particle counting immunoassay (PACLA.) are also available. However, the 
i 
relative sensitivity of these methods and their utility remain to be 
established. 
(2) Normal Values ofSerum Total IgE Concentration 
IgE concentration in umbilical cord serum is usually below 0.5 kU/L. 
Although the human foetus can synthesise IgE as early as from 1 lth-week of 
gestation, there is no appreciable placental transfer of matemal IgE. Serum 
IgE concentration increases from birth and peaks around puberty, thereafter 
42 
it decreases slightly and reaches a plateau after the age of 25 to 30 years 
i (Table 1 • 1，1.2). The upper reference value is about 20 kU/L under the age of 
2 years, 75-100 kU/L between 2 and 6 years, 150-200 kUfL between 7 and 
16 years, and 100-150 kU/L over the age of 20 years. The frequency 
distribution of serum total IgE concentration in normal adults is shewed, 
with wide 95th percentile limit and a disproportionate large number of low 
concentrations. Accordingly, the 95th percentile limit has been treated by 
means of logarithmic transformation. 
Li addition to age related variation, serum total IgE concentrations is 
influenced by genetic, ethnic and seasonal differences [62]. Many 
pathological conditions can also cause elevations in serum IgE. These 
include parasitic infestation, abnormalities in T cell function, viral infections 
and, of course, allergy. Further, environmental factors such as tobacco ； 
smoking have also been shown to increase serum total IgE concentration ‘ 
• :i |1 




Although serum total IgE concentration is generally elevated to >200 kU/L |i 
丨丨 
;j 
in most allergic patients, there are perfectly healthy individuals with | 
i 
^ 
concentrations >1000 ldJVL [62]. Moreover, some severly allergic patients 
may have concentrations <20 kV/L [62]. Therefore the serum total IgE assay 




1.9.6 Allergen Specific IgE levels 
Li contrast to the poor diagnostic efficiency of serum total IgE assay, 
measurement of allergen-specific IgE is of great clinical importance. The 
most widely used method is an immunoradiometric assay known as the 
radioallergosorbent test (RAST) [65]. 
(1) Principle ofRAST 
RAST was first developed in 1967 and subsequently reagent was available 
from Pharmacia for measurement of allergen-specific IgE. Sera for specific 
IgE assay are reacted with specific allergen coupled covalently to a solid-
phase support material. After incubation and washing, captured IgE 
antibodies are incubated with ^^ I^- or enzyme-labelled anti-IgE antibody. ！ 
‘ Specific IgE concentration is proportional to the radioactivity or enzyme 
activity on the solid phase (Fig 1.9). Several modifications have since been 
t" 'i 
made by Pharmacia and other manufacturers including use of Sepharose and I 
？ 
cellulose as solid phase, monoclonal anti-IgE antibody, and fluorescent | 
j 
substrate in enzyme reaction. Is 
u 
(2) Clinical Usefulness of RAST 
Several studies have shown that with the use of standardised allergen 
extracts, RAST results correlate closely with skin tests results. Sensitivity 
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1.9.7 The CAP System 
A significant technological advancement in both serum total IgE and 
specific IgE measurement is the CAP system (Pharmacia). This reagent 
differs from others in that the amount of allergen that is bound to the solid 
phase has been increased using a 3-dimensional cellulose derivative, and the 
enzyme coupled anti-IgE is a combination of both polyclonal and 
monoclonal antibodies. A number of studies have compared the CAP 
system with other in vitro assays, particularly RAST and skin prick test [66, 
67，68]. These studies demonstrated that the CAP system had greater 
sensitivity than the standard RAST, and about the same level of specificity. 
L 9.8 Mixed Aeroallergen Specific IgE Assay (Phadiatop^^) 
As discussed in the preceding sections, serum total IgE concentration is not a 
reliable indicator of allergy, and screening with several specific IgE tests is 
I' 
I 
not cost effective. An intermediate screening test, Phadiatop™ (Pharmacia) |i 
|i 
was developed to differentiate (exclude/establish) the presence of possible ii , 
inhalent allergy with the purpose of providing an easy and reliable screening 
test. The test is similar to the RAST methodology, but many different 
common inhalent allergens are coupled to the test disc/cup. Results are not 
quantitative, but they do indicate the presence (positive test) or the absence 
(negative result) of inhalent allergy. Therefore the patient is defined as 
allergic or non-allergic, and more further investigations, eg, a panel of 
specific IgE tests should be performed if the test result is positive. The 
clinical relevence of Phadiatop has been examined in many studies. Its 
46 
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specificity was found to range from 70% to 80% which is certainly better 






















1.10 Further Notes on Allergic Rhinitis 
L10.1 A Prevalent and Costly Health Problem 
Allergic rhinitis is the commonst allergic disease. Although not life 
threatening, it causes considerable morbidity and results in tremendous 
expenditure in health care and great loss of working and school days [40]. 
Allergic rhinitis is provoked by exposure and sensitisation to environmental 
inhalent allergens. It can be episodic or perennial. When symptoms occur r 
I 
annually during certain months, the syndrome is called seasonal allergic : 
') 
rhinitis. Perennial allergic rhinitis can be constant or recurrent and occurs 丨 
P 
year round. It can also be associated with seasonal exacerbations. ！ 
I 
I w l;l i .| 
it 
L10.2 Epidemiology | 
丨丨 
American cumulative prevalence figures range from 9 to 21% [20]. ：| 
European rates have generally been a little below the American numbers [23， | 
^ 
； 69]. Australia reported what previously was the highest rate, 27% [40]. 
[ Preliminary results from the Memational Study of Asthma and Allergies in 
f Childhood (ISAAC) documented prevalence rates of 21 -45% current rhinitis 
• amongst 13-14 year-old children in SE Asia including Hong Kong (45%) [5]. 
“ Generally, prevalence increases during childhood from 5 to 9 years, with 
i peak incidence at post-adolescence that gradually decreases during 
m.. 
i adulthood. There is little sex difference, race and socioeconomics are not 
m 
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i. 10.3 Symptoms of Allergic Rhinitis 
Allergic rhinitis is an IgE-mediated inflammatory disease of the nasal 
mucosa. The major allergic nasal symtoms are frequent sneezing, water 
rhinorrhoea, and nasal puritis progressing to congestion and blockage. They 
are sometimes accompanied by allergic conjunctivitis, Eustachian tube 
obstruction, otitis media, sinusitis or asthma because of contiguous 
anatomical relationships of the respiratory tract. Most patients develop 
symptoms of allergic rhinitis rapidly (<30 minutes) after exposure to the 
offending allergen. Some patients suffer for years from nasal allergic -
I 
symptoms, especially those with perennial allergic rhinitis. However, a 
i ) 
late-phase nasal allergy with severe nasal obstruction, loss of smell and s 
1) 
mucosal hyper-responsiveness may subsequently prevail, while other nasal \ 
• symptoms (hypersecretion, sneezing and itching) remain present in a milder i 
i ;1 
degree. It has also been reported that alternate nasal obstruction is a ',| 
common nasal symptom in allergic rhinitis. | 
I, 
ii 
r i (I 
I 
1,10,4 ENT Examination | 
^" 
After history taking, the patient can be observed at rest to establish whether 
he/she breaths through the mouth and exhibits an "allergic salute" or "rabbit 
nose habit" which are hallmarks of allergic rhinitis. Examination of nasal 
mucosa can be performed with the use of a nasal speculum or fiberoptic 
rhinoscopy for pathological secretion, oedema, erythema and signs of 
inflammation, or anatomical anomalies. Rhinoscopic examination not only 










infection. However, differentiation between pollinosis or house dust allergy 
and non-atopic vasomotor rhinopathy cannot be made on the basis of 
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1.11 Aims of This Study 
The objectives of the work reported in this thesis are as follows : 
(1) To conduct a survey of the aetiology of allergic rhinitis in Hong Kong 
using laboratory tests for documentation of sensitising allergens and 
percentage of single and multiple allergies. 
(2) To assess the usefulness of serum total IgE, mixed aeroallergen IgE 
(Phadiatop) and specific IgE assays for confirming the diagnosis of allergic 
rhinitis. 
(3) To evaluate the performance of the Pharmacia CAP system for serum r 
1¾ 
IgE assay. [, 
i) 1 • 
\ii > 
i?^  
The above objectives are within the scope of Clinical Biochemistry with \ 
[ I'' 




Objective 1 is an activity in the academic discipline of Chemical Pathology , 
i_ 
which studies the biochemical basis of disease. Li the present work it is ^  
'I 
allergic rhinitis, a very prevalent, debilitating and costly allergic disorder in | 
)\ 
Hong Kong and worldwide. | 
«•’', 
Objectives 2 and 3 are pursuits in the applied-science aspect of Clinical 
Biochemistry, where knowledge and skills in analytical biochemistry are 
utilised in methodology and instrumentation aiding diagnosis, monitoring 
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Evaluation of the 
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2.1.1 Pharmacia Reagents 
The following reagents were obtained from Kabi Pharmacia Diagnostics 
AB, Uppsala, Sweden through Pharmacia Asia Ltd, Hong Kong 
-RAST FEL\ Fluoroimmuno Reagents (Cat. No. 10-9125-01) 
-RAST FELA Standard Reagents (10-9213-01) 
-Lidividual CAP System allergens: 
d l Dermatophagoides pteronyssinus, dust mite (14- 4107-01) r 
::: 
I el Catdander (14-4109-01) ,^  
i ' . 
e2 Dog epithelium (14-4121-01) t ^
 
i6 Blatella germanica, cockroach (14-4224-01) | 
h2 Housedust (14-4140-01) I 
； • 、丨1 
mxl Penicillium notatum, Cladosporium herbarum, Aspergillus fumigatus ？ 
I 
and Altemaria alternate (14-4204-01) 
I, 
g2 Cynodon dactylon, Bermuda grass (14-4131 -01) ^ 
g6 Phleum pratense, Timothy (14-4100-01) | 
w l Ambrosia elatior, common ragweed (14-4162-01) | 
<•'* 
w6 Artemisia vulgaris, Mugworth (14-4103-01) 
-Washing solution (10-9175-01) 
-Specific IgE Control 1 (10-9127-01) 
-Specific IgE Quality Assessment Programme (10-9225-01) 
-Phadiatop® FEL\ fluoroimmunoassay kit (10-9240-01) 
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2. L 2 Abbott Reagents 
JMx™ Total IgE Reagent Pack (Cat. No. 2233-20) for serum total IgE assay 
was purchased from Abbott Laboratories, Abbott Park, JL 60064，USA. 
2.1.3 In-House Reagents 
Phosphate buffer saline _ albumin solution (PBS-Alb) with the following 
composition was prepared using glass-distilled, de-ionized water and ^ 
'9 
Analar-grade chemicals from Sigma Chemical Co, St Louis, MO 63178， :) 
丨： 'i 




0.05 mol/L phosphate buffer, 0.15 mol/L sodium chloride, 4% albumin, pH i 
i 
7.4 '； 
NaH2PO4.2H2O 1.498 gyO. , 
1； 
Na2HPO4 5.735 grL 丨㈣ 
NaCl 9.0 g/L I 
j 






2.2 Apparatus and Equipment 
2.2.1 Pharmacia 
The following components and accessories of the CAP System (FEL\ 
installation) were obtained from Kabi Pharmacia Diagnostics AB, Uppsala, 
Sweden 
I - Microtiter plates (96 wells, Cat. No. 34-2236-21) 
I - taimuno CAP dispenser (12-3215-01) for dispensing immuno CAP into 
:j 
the assay microplate 
•;j 
i - inmuno CAP Rake (12-3218-01) fortransfer of complete rows of immuno 
•] 
CAP between assay microplates 
I 
.Posit ioning Guide 96 (12-3207-01), a microprocessor-controlled 
.1 
workstation which automatically indicates the microplate positions into 
which test samples or standards are to be dispensed manually 
-Assay Washer 96 (12-3205-04) to facilitate the automatic washing and 
elution procedures in the assay process 
-FluoroCount 96 (12-3201-01), microplate reader for fluorescence 
measurement. Data from the reader are transmitted to the master CAP 
information management softwares for calculation of the test results. 
2.2.2 Abbott 
The EVIx analyser (Abbott Laboratories, Abbott Park, IL60064, USA) was 
used for measurement of serum total IgE concentration. 
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2.3 Methods of Evaluation of the Pharmacia CAP System 
Allergen Specific IgE (RAST) Fluorescence Enzyme taimunoassay (FEL^_). 
23.7 Principle of the Pharmacia CAP System RAST FEIA 
fluoroimmunoassay 
The Pharmacia CAP System RAST FEDV provides an in vitro measurement 
of circulating allergen specific IgE in human serum (Fig 2.1). The allergen 
of interest is covalently coupled to a 3-dimensional cellulose derivative 
packaged in a reagent cup called the toimuno CAP. A sample of patient 
serum containing specific IgE is dispensed into the CAP and allowed to react 
with the allergens. After washing, enzyme labelled anti-IgE antibodies are 
L 
added to form a complex with captured IgE. After a second washing, the 
• 
• , 
bound complex is incubated with a developing agent containing 4-
Methylumbelliferyl-P-D-galactoside. Upon stopping the reaction, the 
fluorescence of the eluate from the immunoCAP is measured in FluoroCount , 
96 (excitation 365 nm, emission 450 nm). The higher the fluorescence (in 
FU)，the more specific IgE is present in the sample. FU values of patient 
M 
samples are compared directly with those of standards which are assayed in 
parallel deriving concentration readings in a FU vs log concentration 
standard curve. Concentrations are also evaluated automatically for printing 
of RAST classes: 0 = negative test, and 1-6 positive tests of increasing 
severity. 
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. tf 
Figure2.1 Principle ofPharmacia CAP System RAST FELA. for measurement — 
of specific IgE concentration. (From Reagent package insert of Kabi 
Pharmacia Diagnostics AB, Uppsala, Sweden.) 




2丄2 Assay Preparation and Procedure 
The manufacturer's protocol was followed exactly as follows : 
(1) Anti-IgE immunoCAPs for the standards and appropriate allergen 
immunoCAPs for the samples were added into wells of a microplate. 
(2) The immunoCAPs were prewashed with washing solution using the 
Assay Washer 96. 
(3) 50 ^iL of standards/controls/test sera were pipetted and dispensed into 
the bottom of the wells in a second microplate. 
(4) The prewashed immunoCAPs were transferred row by row to the 
microplate containing samples using an L:nmunoCAP Rake. 
(5) The samples were allowed to incubate for 30 minutes at room 
temperature. 
(6) After 30 minutes, the sample loaded immunoCAPs were washed in 
Assay Washer 96. 
(7) The washed immunoCAPs were transferred to 50 ^iL of Enzyme-
Anti-IgE conjugate in another plate and incubated for 150 minutes. 、 
(8) After 150 minutes, immunoCAPs with conjugates were washed again 
and transferred, row by row, to 50 ^iL of development solution and 
• 
incubated for 10 minutes. 
(9) When incubation was completed, the elution procedure was initiated in 
Assay Washer 96. Note: This automated procedure comprises 4 
cycles, each dispensing 100 ^iL stopping solution into individual wells 
of the microplate, giving a total dispensing and elution volumn of 400 
^iL. 
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(10) Fluorescence of eluates were measured with FluoroCount 96 which 
automatically reads all wells of the microplate and transmits 
fluorescence values to the system's computer. 
(11) Data were analysed by the system's information software (Pharmas) for 
printing of standard curve and patient serum specific IgE results. 
2.3.3 Evaluation Experiments 
These included assessment of precision, accuracy, linearity (assay range), 
and recovery. 
( 1 ) Elution efficiency of assay washer 96 
As mentioned in the assay protocol, the crucial procedure of washing and 
elution was very dependent on the Assay Washer 96. Therefore, the accuracy 
and precision of washer dispensing was first evaluated. 
t 
I 
Gross assessment of elution volume 
i 
An empty microplate was weighed，and the elution procedure was initiated 
with distilled water. The distilled water loaded microplate was weighed 
again. The difference in weight represented total volume dispensed over the 





Precision of elution volume in each well 
A Coomassie Blue dye solution with known absorptivity at 640 nm was used 
as the stopping solution. After completion of the elution cycles, the 
absorbance ofthe dye eluate in each well was read with the Bio-Tek EL 340 
automated microplate reader. 
Overall precision and accuracy of elution through ImmunoCAP 
Working standards of low (L), medium (M) and high (H) specific IgE 
concentrations (3.3，18.3, 55.7 kU/L) were prepared fresh from the high 
calibrator (100 kU/L). Overall performance of elution through tnmunoCAP 
was evaluated by analysing each working standard dispensed into 12 wells 
positioned in a single row. (Washer has 12 nozzles arranged in a row), 
taiprecision of elution at L, M and H concentrations was calculated as 
coefficient of variation (CV) from results of the 12 replicate analyses, and 
accuracy as % deviation of measured concentrations (mean of 12 results) ‘ 
I 
from corresponding values. 
1 
I 
fi I. I 
(2) Precision ofRASTFEIA ( 
p 
This was assessed using a commercial control serum (Specific IgE Control I 
#72-3025-00/17, Pharmacia) from which 2 sets of samples of low (L)， 
medium (M) and high (H) concentrations were prepared, as appropriate, by 
dilution with phosphate buffer saline-albumin solution. Twenty (20) 
replicate analyses were performed on each of a set of samples over 20 days 
for assessment of between-batch imprecision, and the other set of samples 
was assayed simultaneously 20 times for study of within-run imprecision. 
丨 6 0 
(3) Accuracy 
Serum samples from the Allergy Quality Club (Specific IgE External Quality 
Assessment Programme, Pharmacia, Uppsala, Sweden) were assayed. 
Measured values were compared with the consensus mean and the method 
standard deviation. The bias of a result was calculated as the deviation from 
the mean standard deviation value and expressed as standard deviation index 
using the formula 
SDI = measured value - mean value 
mean SD. 
(4) Linearity and detection limits 
Linearity of the assay was assessed by serially diluting the highest IgE 
standard (concentration 100 kUyT )^ with phosphate buffer-saline albumin 
solution, pH 7.4 to 75.0，35.0, 25.0，17.5,10.0, 7.5, 3.5, 1.75，0.70 and 0.35 
kU/L and assaying the neat and diluted standards in duplicate. Linearity was \ 
estimated visually as the range of constant slope, and detection limit 
determined either as the y-intercept of the regression line i f no change in 
• 
f 
slope had occurred at lower concentration or the point of deviation of slope 
I 
of the regression line at lower concentration. 
p 
(5) Recovery study 
Two patient sera with known specific IgE concentration (0.35 and 0.7 kU/T^) 
were spiked with different volumes of standards (17.5 and 50 kUfL) to final 
concentrations of7.3,10.6,19.9,29.7 k^J^L covering a substantial portion of 
the analytical range. Each sample was analysed in duplicate. The 




MATERIALS and METHOD II 
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Aetiology of Allergic Rhinitis 
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3.1 Patients and Controls 
Fifty seven patients (26 males and 31 females; mean 土 SD age 二 25 士 11 
years, range 10 - 62) were recruited at the ENT Outpatient Clinic of the 
Prince of Wales Hospital from October 1994 to May 1995，with allergic 
rhinitis diagnosed by an otorhinolaryngologist (Dr H K Fung) using 
established criteria based on history and rhinoscopic examination [73]. The 
same number of sex and age-matched (to 土 5 years in same decade) controls 
(26 males and 31 females; age 二 24 士 10, range 11 - 65 years) were identified 
over the same period amongst my laboratory colleagues, their friends and 
/• 
relatives, with allergic rhinitis and other forms of allergy excluded by 
rhinoscopy (same ENT surgeon) and negative history in a questionnaire 
survey (see attached page) which enquired current and previous symptoms ； 
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3.2 Blood Samples 
i' 
fi •1 'i 
A 10 mL venous blood sample was collected from each patient and control : 
«! 
subject and allowed to clot for about one hour. Serum was separated by 
centrifugation 3000 rpm for 15 minutes at 4°C. Al l sera were stored at -70°C 
before they were assayed for total IgE, mixed aeroallergen specific IgE 
(Phadiatop), and a panel of allergen-specific IgE. 
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I Name : 
j ALLERGIC RHINITIS QUESTIONNAIRE 
I ① Circle the symptoms listed below if you have it/them frequently, 




② Would you regard your symptom/s to be mild, moderate orsevere? 
③ Which is the most predominant one? 
④ Work through the following questions for the most predominant symptoms. “ 
[ 
(' 
a) Which month/s in a year does your symptom occur? — 




b) What is the time in a day that it affects you? ;； 
;! 
Morning / Noon/Afternoon / Evening / Bedtime ; 
,1 
I 1^  i' 





d) Does your symptom come when there is a sudden change of temperature? ‘ 
Yes/No 
⑤ Do you have any of the following medical problem/s? 
Asthma / Eczema / Food Allergy / Utricaria 







3.3 Serum Total IgE Assay 
This was performed using the Abbott M x analyser and its Total IgE Reagent 
Pack (2.12 and 2.2.2) with a measuing range of 4 to 4000 kJJ/L and an 
intra-assay coefficient of variation of 3.0% at 80 kJJfL in our laboratory. 
The analyser has been designed for Microparticle Enzyme taimunoassay 
(MEDV) (Fig. 3.1). It uses a submicron microparticle coated with a capture 
I molecule specific for the analyte being measured, eg, anti- IgE antibodies for 
I IgE. The effective surface area of the microparticles increases the assay 
kinetics and decreases assay incubation time, permitting MEL\ assays to be : 
/". 
completed more speedily than other immunoassays. The analyser transfers 
sample and microparticles to the incubation compartment of the reaction 
^i 
well. During the incubation period, IgE binds to the microparticle forming 1 
丨 H 
an immune complex. Then the system transfers an aliquot of the immune 1 
’ 、丨 
complex to the reaction well's glass fibre to which the immune complex is '^  
irreversibly binded. The unbound materials are washed away through the ‘ 
？ 
layer pores in the matrix. Alkaline phosphatase-conjugated anti-IgE is then ) 
dispensed to bind the immune complex. The matrix is then washed again and ;| 
the fluorogenic substance, 4-Methylumbelliferyl phosphate (MUP) is added I 
<n> 
to the matrix and fluorescence of the product 4-methylumbelliferone (MU) is 
measured by the MElA optical assembly. The rate at which MU is generated 
on the matrix is proportional to the concentration of IgE in the test sample. 
:i 65 
1 . :::i 
The foUowing is an iUustration of the typical MEL\ reaction process: 
% ; 3 -綠：. 
‘Anti-Analyte Miaopartide Sample Andbody-Antigen Complex 
* 
• .-
. , 、 
AUaUne Phosphatase' ‘ ' ^ ^ 
.+ 论 — W ^ ^ - -
^ ^^m»>^ 
• I , 
• • :-' • S' ,^. . , 1 ^ .^ . Mtibody-Andgen-MtibodyComplex i, 
Mh-Malyte-Speohc Captuied by the MHA Reaction Cdl 
ABcPhoaConjugate , GhisHberMatrix . 
I 
^ — J| 
, , 丨 
+ ® 一 • —: 碑 \ 
, 、 藝 > ^ , 
«•' 
Me thylumbeUi/erone 
4-MethyluB^ bem/eryl Andbody-Mtigen- ^ b fluorescent 
Phosphate 0 ^ ) Andbody Complex '^® ofMUproduction ls mea5ured. • 
•MElA schematic reaction sequenca 
Figure 3.1 Principle of microparticle enzyme immunoassay (MEDV) for 
measurement of serum total IgE concentration using JMx analyser. (From 
JMx system operational manual, Abbott Laboratories, Abbott Park; EL60064， 
USA). 
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3.4 Mixed Aeroallergen Specific IgE Assay (Phadiatop) 
I Sera of the patients and control subjects were screened for the presence of 
specific IgE vs common inhalent allergens using the CAP system Phadiatop 
FEL\ (Pharmacia). Utilising the same principle as RAST FEDV (Section 
f 
I 2.3.1), this test has been designed for screening of inhalent allergy. The 
[• 
reagent consists of a mixture of common inhalent allergens covalently 
coupled to the LnmunoCAP for capturing specific IgE antibodies. After 
incubation and washing, p-galactosidase-labelled anti-IgE antibody is 
added to form a complex, which is measured fluoro-enzymatically as in ； 
RAST FEL\. The fluorescence derived from the test serum is compared with 
that for a reference semm (Pharmacia Cat No 72-3048-00/16) to establish the 
N 
presence (positive test) or the absence (negative test) of specifice IgE vs ; 
t* 















Statistical analysis of data obtained from aetiological study of allergic 
rhinitis was performed with an AST Bravo LC 4/66 d personal computer 
using Abstat™ statistical software version 2.0. The %^  test was used to assess 
the association between categorical variables, eg, positive and negative 
Phadiatop and serum specific IgE tests. The non-parametric Mann-Whitney 
test was chosen for comparison of difference between 2 groups of numerical 
results, eg, patient vs control serum total IgE and specific IgE 
concentrations. A probability (p) value <0.05 was considered as significant. 
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The above statistical methods were selected according to the nature of the 
data being evaluated following an established procedural flow-chart (Fig. 
3.2) [71], 
Comparison between patients and controls of the proportion of 
positive/negative Phadiatop and specific IgE results, which are discrete data, 
requires the use of the ^ test. 
Patients and control subjects have been recruited at random, their serum 
samples and total IgE and specific IgE concentrations measured are 
independent ofeach other. From Section 1.9.5 we expected the distribution 
of concentration values would be non-parametric. Under such 
circumstances, the Mann-Whitney test should be used to assess the 
hypothesis that "one population produces larger observation that the other，，. 
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STATISTICAL PROCEDURES 
FOR TWO INDEPENDENT SAMPLES 
Comparison of proportions ？ 
Yes ^ ^ ^ ^ ^ ^ ^ " ^ No 
I _i 
Two-sample Association or 
Z test comparison of populations ？ _ i ~ 
Association Comparison of 
populations 
* i • 
Chi-square test Both populations normal/ 
ofassociation approximately normal or 
at least 1 population 
extremely nonnormal? 
^ ^ 1 
Both populations normal/ At least 1 population 
approximately normal extremely nonnormal 
i _ * 
Ratio of sample variances Mann-Whitney 
between 0.5 and 2? test 
. H - ^ ^ ^ ^ ^ _ _ 
Yes No 
• •  •〒 ,丫 
Pooled-vanance Separate-vanance 
t test t test 
Figure 3.2 Statistical procedure for comparison of two independent 
samples. (From Shott S. Statistics for health professionals. Philadelphia : 




Evaluation of the 
Pharmacia CAP System 
7 0 
The elution efficiency, overall precision and accuracy, linearity and recovery 
of this semin-automatic CAP analyser utilizing fluorescence enzyme 
immuniassay (FELA.) for specific IgE measurement were evaluated and the 
results are presented below. 
4.1 Elution Effiiciency of Assay Washer 96 
As explained in Section 2.3.2, the crucial final step in the FEL\ procedure is 
stopping the enzymatic reaction in the reagent CAPs and simultaneously 
eluting the fluorescenct product into microliter wells for fluorometric 
measurement. Thus successful completion of the assay is dependent on 
optimal functioning of the analyser's assay Washer 96, which performs the 
elution process automatically beyond the analyst's control. Therefore, 











I 4丄1 Gross Assessment of Elution Volume 
The elution process of the washer comprises of 4 repeated cycles，each 
I dispensing 100 ^iL stopping solution into individual wells of the microplate 
j 
I giving an overall elution volume of 400 ^iL. Therefore, the total volume of 
solution dispensed into the 96 wells should be 38.40 mL. tfwater is used as 
the elution solution，the difference in weight between the distilled water -
loaded and the empty plate should represent the total weight of water 
dispensed over the 4 cycles of elution which should in tum equal to the total 
volume of water dispensed into the 96 wells of the microplate (taking the 
1 .'i 
•:| • ! 1 
i 1 
7 1 
density of water at 25。C = 1.00 g/mL). The above assessment was carried 
out once and the result were: 
weight of empty reading plate 二 55.75 g 
weight of distilled water loaded plate = 94.136 g 
difference in weight = 38.386 g 
ie, total volume of water dispensed = 38.386 g. 
From this weighing experiment, the dispensing volume was found not 
greatly deviated from the expected volume (deviation = -0.036%). 
4.1.2 Precision ofElution Volume in Each Well 
This was assessed as described in 2.3.3 (1). The absorption spectrum of 
Coomessie Blue with a Xmax at 648.5 nm is shown on Figure 4.1. When this 
dye solution was used as an elution solution, the mean integrated absorbance 
I 
at 640 nm ofthe eluant in the wells (n=96) was 0.433 absorbance unit with a 
SD of 7.03 X 10_3 unit giving a very satisfactory CV of 1.62% (Table 4.1). 
Combining the above good precision in elution volume among the 96 wells 
with the accurate mean elution volume calculated in 4.1.1, it can be deduced 
that washer has been capable of dispensing accurately and precisely 400 ^il 
of elution solution into each well ofthe microtitre plate. 
！ 
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Figure 4.1 Absorption spectrum of Coomessie Blue. A stock solution 
(0.05% w/v) was diluted 1:5 (v/v) in distilled water and absorption spectrum 
determined with a spectrophotometer. 
丨 ‘ 73 
:i . 
Table 4.1 Absorbance readings at 640nm of Coomessie Blue solution in 
microtitre plate. 
i 2 3 4 5 6 7 8 9 I o ~ U I T " 
A 0.432 0.416 0.433 0.442 0.427 0.432 0.437 0.434 0.435 0.433 0.433 0.435 
B 0.419 0.423 0.442 0.438 0.433 0.438 0.432 0.436 0.425 0.439 0.437 0.438 
C 0.430 0.408 0.421 0.436 0.436 0.415 0.437 0.430 0.432 0.422 0.432 0.440 
D 0.421 0.424 0.431 0.439 0.436 0.432 0.434 0.435 0.432 0.448 0.440 0.436 
E 0.425 0.427 0.437 0.437 0.435 0.424 0.424 0.439 0.441 0.437 0.446 0.437 
F 0.425 0.429 0.440 0.442 0.436 0.433 0.429 0.439 0.436 0.434 0.434 0.441 
G 0.424 0.429 0.432 0.432 0.431 0.428 0.452 0.426 0.445 0.435 0.433 0.431 
H 0.426 0.423 0.441 0.436 0.435 0.415 0.436 0.442 0.441 0.441 0.440 0.430 
« 
Total number of wells (n) 二 96 
Mean absorbance ( x ) 二 0.433 units 
Standard deviation (SD) = 7.03 x 10"' units 









4,L3 Overall Precision andAccuracy ofElution through ImmunoCAP 
Results are summarized on Table 4.2. CV of the low, medium and high 
standards (3.3,18.3 and 55.7 kU/L) were 5.6,7.8 and9.6%, respectively (n = 
12). Accuracy was expressed as deviation of measured concentration (mean 
of 12 results) from actual concentration and corresponding values were +2.7， 
-0.55 and 0% for the three levels. 
4.2 Precision of RAST FEIA 
Within-batch CV were 5.1，6.0 and 8.3% respectively at low, medium and 





i « ^ 1^  
4,3 Accuracy 
1« 
Results of this evaluation are listed on Table 4.4. Over the 6-month 
assessment period, our assay was found to be generally accurate with a slight 




Table 4.2 Overall Precision and Accuracy of Assay Washer 96. 
“Spec i f i c IgE Mean ±SD ^ Deviation*~" 
standard (kU/L) (kU/L) (%) (%) 
3.3 3.39 土0.19 5.6 2.7 
18.3 18.2 士1.43 7.8 -0.55 
55.7 55.7 ±5.36 9.6 0 



















Table 4.3 Precision of specific IgE assay using CAP System 
Specific IgE control Mean ±SD C.V. 
(kU/L) (%) 
Within-Batch (n = 20) 
L 1.92 土0.97 5.1 
M 9.26 ±0.56 6.0 
H 30.9 士2.58 8.3 
Between-Batch (n = 20) 
L 1.92 ±0.08 6.5 
M 8.09 ±0.44 5.5 











Table 4.4 Comparison of measured specific IgE concentrations with 
consensus values in an external quality assurance programme. 
Quality Assayed Consensus Target SD SD 
assurance value value Index 
sample (kU/L) (kU/L) (kU/L) 
1 Kso Ku 1 ^ 0 
2 20.80 23.45 3.35 -0.8 
3 1.92 1.98 0.34 -0.2 
4 9.74 11.88 2.41 -0.89 
5 6.21 6.98 1.12 -0.69 
6 15.8 18.09 2.73 -0.84 
SD todex 二 assayed concentration - consensus value ； 
_^^^ _^«^ _^«^ _^^«^_—«««<^«»««™»«««««^~^ "^""""""""^""""" '' 






4.4 Linearity and Detection Limit 
As described in Section 2.3.3 (4)，linearity of the assay was assessed by 
serially diluting the highest IgE standard (concentration 100 kJJfL) with 
phosphate buffer-saline albumin solution, pH 7.4 to 75.0, 35.0, 25.0, 17.5, 
10.0, 7.5, 3.5, 1.75, 0.70, 0.35 kU/L and assaying the neat and the diluted 
standards in duplicate. The standard curve of the specific IgE assay is shown 
on Fig. 4.2 and the linearity plot on Fig. 4.3. The assay was linear from 0.35 
up to 100 kUfL. 
Based on the above finding, detection limit was set at 0.35 kJJfL, which is (1) 
the lowest point ofthe standard curve within our confirmed linearity range, 
and (2) a clinically appropriate low concentration for negative sensitisation. 
0 
A print out of <0.35 kJJfL from the analyser was taken as 0 kU/L and ； 






Results are shown on Table 4.5. Recovery of the specific IgE assay ranged 




• • • 
Response (FU) .. • .. 
24000 n — “ 
.LUJ_^—/. 
18000 7 ^_^d/_ . 
1 2 0 0 0 ~ ~ 7 
M M ^ _ 
6000 “ ~y 
QLZ_ : 
^ E ^ ¾ " " • - ^ " " * * “ ^ ii 
o-ooo ——_o^r^^ r S ir!"i i ^ ~ ^ 0 0 




Figure 4.2 Standard curve of specific IgE assay as plotted by the CAP 
analyser. FU was the fluorescence in a microtiter well measured by the 
FluroCount 96. 
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Figure 4.3 Linearity plot of specific IgE assay 
• • . 
丨 8 1 
* ^ 
Table 4.5 Recovery of Specific IgE Assay 
Patient serum Expected value Observed values^ % Recovery 
(kU/L) (kU/L) 
1 7.3 6.76 92.6 
10.6 10.4 97.6 
2 19.9 18.2 91.2 
29.7 27.9 94.1 
















Aetiology of Allergic Rhinitis 
in Hong Kong 
8 3 
5.1 Patients and Controls 
f 
Fifty seven patients (26 males and 31 females; age 25 土 11，range 10 - 62 
years) and the same number of sex and age-matched controls (26 males and 
31 females; age 24 土 11, range 11 - 65 years) were recruited as described in 
Section 3.1, 
5.2 Serum total IgE, Mixed Aeroallergen IgE (Phadiatop) and 
Specific IgE 
Results ofthe above measurements (totalling 11 assays on each ofthe 114 
patients/controls) are listed on Table 5.1. 
5.2.1 As shown on Table 5.2, allergic rhinitis patients had significantly 
higher serum total IgE concentrations compared to controls (mean ±SEM of 
496 土 88 vs 179 土 38 kUyT^ ，p < 0.0005，Mann-Whitney test). However，the 
distribution ofthese two groups of results (Fig. 5.1) showed an overalapping 
range from about 22 to 1000 k^JfL, with modes of 200 and 80 for patient and 
control values, respectively. 
5.2.2 On Table 5.3, 54 of the 57 patients (94.7%) gave a positive Phadiatop 
test; compared to a significant lower proportion amongst control subjects 
(19/57 = 33.3o/o; p < 0.0005, x' test). 
8 4 
Table 5.1 Results of serum total IgE, mixed aeroallergen specific IgE 
(Phadiatop) and specific IgE assays of 57 allergic rhinitis patients and 
matched controls. Serum specific IgE vs the following allergens were 
measured. 
Dermatophagoides ptemyssinus (dl) 
Blatella germanica, cockroach (i6) 
Cat dander (el) 
Dog epithelium (e2) 
Penicillium notatum, Cladosporium herbamm, Aspergillus fumigatus 
and Altemaria alternate (m x 1) 
Cynodon dactylon, Bermuda grass (g2) 
Phleum pratense，Timothy (g6) 
Ambrosia elatior，common ragweed (wl) 
Artemisia vulgaris, Mugworth (w6) 
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Figure 5.1 Frequency distribution of serum total IgE concentration “ _ ”， 















































































































































































































































































































































































































































































5.25 Table 5.3 also shows the prevalence of sensitisation to individual 
aeroallergens in patients and controls, using serum specific IgE 
concentration >0.35 kUyTL as positive test of sensitisation. 
Jn the former group, house dust mite sensitisation was most prevalent 
affecting 51 of 57 patients (89.5%), while 42.1% of patients had positive 
specific IgE tests vs cockroach. This was followed by sensitisation to cat and 
Bermuda grass (14.0 and 15.8%), and down to dog, mould mix and other 
grass and weed pollens tested (all <10%). House dust mite sensitisation was 
also demonstratedin 25 of57 control subjects (43.9%). Positive specific IgE 
test for cockroach was 8.8%. Less than 6% controls had been sensitised to 
other allergens tested, and none (0%) were positive for cat and dog allergens. 
Statistical evaluation of the above results, using %^  test as for analysis of 
Phadiatop data, showed that patients had increased proportion of 
sensitisation to house dust mite, cockroach, and cat dander compared to 
controls (all p <0.005). 
S,2,4 The degree or severity of sensitisation to aeroallergens between 
patients and controls was compared by performing Mann-Whitney test on 
corresponding groups of serum specific IgE concentrations (Table 5.2). 
Patients had significantly higher specific IgE concentrations vs house dust 
mite, and cockroach compared to controls (all p <0.05). Between the two 
groups, there was no significant difference in specific IgE concentrations vs 
other allergens measured, including IgE vs cat dander (p=0.07), which was 
shown above to have an increased proportion ofpositive tests in patients. 
！ 9 3 
•！ 
i 
5.2.5 Of the 54 patients (94.7% of patient group) with positive Phadiatop 
screening test, 47 (87.0%) had multiple inhalent allergy with positive 
specific IgE tests to at least 2 aeroallergens. They were therefore atopic by 
definition and most (46) were sensitised to house dust mite. Four (7.4%) of 
the 7 remaining Phadiatop-positive patients presented with single allergy 
(exclusively vs house dust mite and no other allergens). The 3 patients left 
who were Phadiatop positive showed no detectable specific IgE vs all 
allergens tested. 
5.2.6 Usefolness of the Phadiatop test in confirming the diagnosis of allergic 
rhinitis in the absence of other inhalent allergy was assessed in terms of its 
sensitivity (% positive tests in patients) and specificity (% negative tests in 
controls). Thus in our study : 
sensitivity 二 number of positive results x 100% 
total number of patients 
=5A xlOO% ^ 
=94% 
• 
specificity = number of negative results x 100% 
total number of controls 





Evaluation of the 
Pharmacia CAP System 
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6.1 Elution Efficiency of Assay Washer 96 
As explained in Section 2.3.1，the principle of the Pharmacia CAP FELA. for 
serum specific IgE assay is based on capturing of specific IgE antibodies in 
patienfs serum with specific allergen covalently coupled onto 3-dimensional 
cellulose in the reagent cup (CAP). After incubation and washing, the 
captured specific IgE in tum retain enzyme-labelled anti-IgE antibodies 
added to the CAP. Subsequently the enzymatic reaction is initiated to yield 
a fluorescent product, the amount of which is proportional to the patient's 
specific IgE concentration. 
The crucial step ofthe assay relies on optimal functioning of the analyser's 
Washer 96 in stopping the enzymatic reaction and eluting the fluorescent 
product into a microtitre plate for measurement. Assessment of elution 
precision and accuracy was therefore treated as a first priority and carried out 
extensively in three successful stages. 
First, we made a gross assessment on the accuracy of elution volume (400 ^iL 
per well in four 100 ^iL cycles) by converting the difference in weight of a 
microtitre plate before and after elution with distilled water (density 二 1.00 
g/mL at 25°C) to total volume dispensed. The latter was calculated to be 
38.386 mL per plate of96 wells, or an average of 399.9 ^L per well, a very 
satisfactory volume compared to the Washer's specification of400 ^L. 
We then assessed precision of elution volume by measuring integrated 
absorbance at 640 nm of the wells after elution with a Coomessie Blue 
9 6 
solution. The observed CV of 1.6% from the elutions (n = 96) was equally 
encouraging. 
Finally, overall precision and accuracy of elution through LnmunoCAP was 
studied to simulate Washer performance in the FELV at low, medium and 
high specific IgE concentrations. It can be concluded from the results 
obtained (CV = 5.6 - 9.6%, bias of-0.55 to 2.7%) that Washer 96 operation 
was efficient and elution was both accurate and precise. 
6.2 Within-Batch and Between-Batch Precision, Accuracy, 
Linearity and Detection Limit, and Recovery of FEIA 
The above parameters were studied as described in Sections 2.3.3 (2) - (5)， 
with results shown in Fig. 4.2 and 4.3，and Table 4.3 - 4.5. Within-batch and 
between-batch precisions were satisfactory (CV from 5.1 to 9.1%) at low, 
medium and high specific IgE concentrations over the calibrated range, and 
test results were found to be accurate with little bias from consensus values. 
The assay was linear from 0.35 - 100 kVfL covering concentrations of 
negative to strongly positive allergen sensitisation. Analytical recovery was 
also close to 100%. 
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6.3 Overall Evaluation 
The Pharmacia CAP analyser is a semi-automatic instrument designed for 
measurement of serum total and specific IgE concentrations. The CAP 
reagent which it uses has much improved IgE capturing capacity over the 
previous paper disc and other 2-dimensional surfaces, thereby increasing 
substantially sensitivity of the assay, particularly with the Phadiatop test. 
Fluorescence enzyme immunoassay is the methodology employed and the 
indicator reaction is measured in a microtitre plate by fluorometry of the 
individual wells. Up to 80 assays in any number and any combination of 
different specific IgE tests can be performed on a 96-well plate within 4 
hours with occasional manual steps. Throughput is faster when more than a 
plate of samples are analysed with time saved by overlapping incubation 
periods. 
We found the analyser easy to operate requiring little time (eg, 1/2 day) for 
staff training and familiarisation. The design of the CAP reagent and its 
special accessories (eg: Position Guide, taimunoCAP rake and dispenser) 
enabled otherwise tedious and time consuming manual procedures to be 
carried out very efficiently. The analytical performance of the FEL\, as 
discussed above, was satisfactory. We have been using the instrument very 
successfully in analysing both large-batch research samples as well as 
small-batch specimens from our University Private Pathology Service. 
Use ofthis analyser also provides yet another illustration of the advantages 
of serum assays over skin tests for allergy. For the former, only one blood 
sample is required for assay of different specific IgE antibodies and it is also 
9 8 
possible to preserve the sample for subsequent further investigations. More 
importantly, serum assays yield quantitative and potentially more objective 
results. Unlike skin testing which uses at best a semi-quantitative scoring 
system (0 to 4+) for grading of sensitisation，the CAP system reports 
quantitatively the concentrations of different allergen-specific IgE 
antibodies in serum which can be related to the severity of allergen 
sensitisation. These concentrations can also be used to monitor the progress 
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7.1 Patients and Controls 
Patients in this study have been recruited from the ENT Specialist Clinic at 
the Prince of Wales Hospital. A l l of them had unresolving symptoms of 
rhinitis and had been referred by their primary care physicians. Diagnosis of 
allergic rhinitis was made by Dr H K Fung (ENT Specialist) using 
established criteria from detailed medical and family history, plus general 
physical and otorhinolaryngological examination [1]. Patients with allergic 
rhinitis but no other allergic diseases were included consecutively into our 
study. 
From the demographic data in section3.1, patients' age ranged from 11 to 62 
with a mean of 25 and a mode of 20 years. These are in full agreement with 
corresponding findings in surveys of several other populations [72，73] that 
allergic rhinitis is most prevalent amongst young adolescents. 
The control subjects, who had been sex and age-matched (to ±5 years in the 
same decade) with patients, were my laboratory colleagues, their friends and 
relatives. They should all have good educational and intellectual levels to 
understand and complete the questionnaire that was explained to them. 
Those with no past and present history of allergic rhinitis and other allergic 
diseases were questioned and examined by the same ENT surgeon (Dr Fung) 
before they were finally admitted to our study. The above procedure was to 
facilitate our specific study of allergenic sensitisation in allergic rhinitis after 
controlling for other factors (age, sex and other allergy) that would influence 






7.2 Serum Total IgE Concentration 
As explained in Section 1.9.1，a detailed medical history and thorough 
physical examination are essential for diagnosis of allergic rhinitis and 
patient assessment. Rhinoscopy is helpful in confirming rhinitis and 
excluding non-atopic aetiology such as anatomical deviation of the nasal 
septum. Since allergic rhinitis is an IgE-mediated hypersensitivity， 
measurement ofIgE antibodies is a logical step in confirming the diagnosis 
and for assessment of severity. 
]n our study, allergic rhinitis patients were found to have significantly 
elevated serum total IgE concentrations compared to controls (mean ±SEM 
of496 土88 vs 179 土 38 kU/L, p<0.005, Section 5.2). However, there was a 
substantial overlapping of results between the two groups from about 22 -
1，000 kU/L (Fig. 5.1), thereby rendering the measurement not a useful test 
for confirming/excluding the diagnosis except when concentrations are very 
high or very low. 
The above observation and generalisation are in line with my introductory 
review of this assay in 1.9.5. Serum total IgE concentration is usually 
elevated in most atopic individuals but its magnitude correlates only 
generally to allergic exacerbation depending on (1) the nature or "potency" 
of the allergens; (2) the degree of exposure and sensitisation; and (3) 
presence of single or multiple allergies. Together these variables are the 
major cause ofthe very wide spectrum of serum total IgE concentations seen 
in our patients (range of >2,000 kUfL probably from multiple and severe 
allergy down to <20 kU/L from an early single sensitisation). 
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On the other hand, there are also many non-allergic conditions which may be 
associated with elevation of serum total IgE concentration (Table 1.3 )• 
Among these conditions parasitic infestation was previously estimated to 
have a 30% prevalence in Asia, although this rate should be lower in Hong 
Kong [74]. Therefore it is not unexpected to find some control subjects 
having a markedly elevated serum total IgE concentration. 
Although some authors have advocated serum total IgE concentration to be 
the temperature or ESR of allergy (cf pyrexia and raised ESR in infection/ 
inflammation) [75], there are serious reservations. The wide overlapping 
atopic and non-atopic ranges in our experience as well as others, together 
with problems in deciding on an optimal discrimint value [26]，result in the 
poor specificity and limited useftilness of this parameter for diagnosis of 
allergy. 
However, it should be agreed that serum total IgE assay is of clinical values 
when: 
-the result is very low or very high (excludes/confirms allergy). 
-measured in cord blood for predicting later allergy [76]. 
_ monitored serially for preventing onset of allergic symptoms [77]. 
7,3 Efficiency of Phadiatop ™ Screening Test 
As discussed above, serum total IgE concentration cannot serve as a specific 
indicator of allergy and is oflimited usefulness in confirming the diagnosis 
of allergic rhinitis. An alternative approach would be to perform a panel of 
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specific IgE measurements for detecting significant allergen sensitisation. 
But this is expensive at about HK$ 60 reagent cost per specific IgE assay, 
insensitive i f only 1 or 2 allergens are tested for, and not cost-effective as a 
first line test i f an exhaustive panel is chosen for reliable results. The 
Phadiatop test (marketed by Pharmacia since 1985) and other equivalent 
mixed aeroallergen specific IgE assays have been developed for screening of 
inhalent allergy. 
Based on the same principle as individual specific IgE assays, these reagents 
contain a mixture of common inhalent allergens for capturing specific IgE 
antibodies in patient's serum. The captured specific IgE in tum retain 
labelled anti-IgE added to the assay system, and the label gives an amplified 
signal which is translated into a qualitative (positive or negative) screening 
test for inhalent allergy. The Phadiatop test in our study utilises a 
fluorescence enzyme immunoassay (Section 3.4), and the 3-dimensional 
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cellulose derivative in the CAP reagent has a much increased surface area for 
coupling of a large amount of >10 common inhalent allergens to greatly 
improve the sensitivity ofthis screening test over previous reagents using a 
2-dimensional paper disc. 
In using this screening test for aiding the diagnosis of allergic rhinitis in 
patients with negative medical history and clinical manifestation of other 
allergic diseases, it is standard clinical biochemistry practice to perform an 
assessment of its sensitivity and specificity. Sensitivity (= positivity in 
disease) ofatest characterises the incidence of true positive results obtained 
when the test is performed on patients known to have the disease; while 
specificity (= negativitiy in health) marks the incidence of true negative 
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results when the test is applied to subjects known to be free of the disease 
[78]. An absolutely efficient and clinically useful screening or diagnostic 
test should have 100% sensitivity and specificity but, as confirmed by 
Professor DN Baron [79]，such ideal test does not exist. 
]n our assessment from this study, the Phadiatop test had a 94.7% sensitivity 
and 66.3% specificity. These figures are not in deviation from sensitivity 
values exceeding 90% and specificity range of 70 - 80% reported in many 
studies for the same or similar purpose of screening for inhalent allergy [69， 
80，81]. Several reasons may account for the false-negative Phadiatop tests 
(5.3%, a very small proportion) in our study. 
First, although the reagent has a wide coverage containing an extensive panel 
of over 10 so-called common inhalent allergens, it may not have included 
some naturally occurring allergens to which some of the patients have been 
exposed and sensitised. Examples may be an indoor or outdoor fungus 
especially abundant in the patient's occupational or living environment, or 
some local pollens not included in the panel. 
Secondly, air pollution has been a frequently quoted adjuvant factor for 
allergic sensitisation and increased prevalence of allergic rhinitis in 
industrial countries and urban areas [82, 83]. Diesel engine exhaust, 
cigarette smoke, volatile organic/inorganic compounds (eg, nitrogen 
dioxide, sulphur dioxide) and air-bome pollutants can influence IgE 
synthesis and mast cell stability [84]. 
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Thirdly, as discussed for serum total IgE assay in Section 7.2, allergic 
manifestation might sometimes be associated with low serum specific and 
total IgE concentrations. 
The substantial proportion (33%) of positive Phadiatop tests amongst 
controls has to be explained too. It is possible that some of the subjects 
might have a mild sensitisation to one or more allergens without clinical 
manifestations (Section 7.2). Jn addition, response to the standard 
questionnaire for past and present allergy can be subjective and affected by 
cultural beliefs or personal unwillingness to disclose medical history. Some 
subjects might have a mild allergy in the past which they did not even aware. 
Thus they actually constituted a group of atopic patients rather than control 
subjects. This may partially account for the low specificity of the Phadiatop 
screening test. 
In summary, the Phadiatop test was useful in our study for confirming the 
diagnosis of allergic rhinitis in the patient group. It certainly has an 
improved clinical utility over serum total IgE assay (and probably skin prick 
test too) for efficient screening purpose. However, this test is only 
qualitative providing a positive/negative result. Identification ofsensitising 
allergen(s) and assessment of severity have to rely on further investigation 
using serum specific IgE assay. 
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7.4 Serum Specific IgE Assay and Aetiology of Allergic 
Rhinitis in Hong Kong 
A primary objective of our study has been to survey the aetiology ofallergic 
rhinitis in Hong Kong. This was attempted by performing semm specific 
IgE tests on both patients and controls using the Pharmacia CAP system. 
These tests give both qualitative (>0.35 kU/L 二 positive) and quantitative 
(specific IgE concentration in kU/L) results and their advantages over skin 
tests has been explained in Section 1.9.4. 
We have selected an extensive panel of common indoor and outdoor 
aeroallergens comprising house dust mite, cockroach, cat and dog dander, 
mould mixture and 4 local prevalent pollens: Bermuda and Timothy grass, 
ragweed and mugwort. 
7.4.1 Major Allegens in Allergic Rhinitis 
As reported in Section 5.2.3-4, patients had significantly increased 
proportion of sensitisation to house dust mite, cockroach and cat compared 
to controls (all p<0.005, y^ test). Dust mite sensitisation was most prevalent 
affecting 89.5% ofpatients，and also most severe (mean ±SEM specific IgE 
of43.0 土 4.80 compared to 6.96 土 2.50 k\5rL in controls; p<0.005, Mann-
Whitney test). Cockroach was the second most important allergen with 42% 
patient positively sensitised to less severely elevated specific IgE 
concentrations of 1.75 士 0.17 kU/L compared to corresponding figures of 
8.8% and 0.30 士 0.13 kU/0. in controls (p<0.005 and 0.05, respectively). 
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Sensitisation of patients to cat dander, although more prevalent than controls 
(14 vs 0%, p<0.005), was not severe enough to result in significant 
difference in specific IgE concentration between the two groups. Some 
aspects of these and other allergens are discussed below. 
7,4.2 House DustMites 
House dust mites of the genus Dermatophagoides (major species 
pteronyssinus mdfarinae) are the most important indoor allergens. Dust 
mites are eight-legged animals that are close relatives of ticks and spiders. 
They grow in warm areas (20-30。C) with high relative humidity (60 - 80%) 
and feed on human skin scales. The major allergen, Derp I (24 kDa)，which 
is abundantly present (94%) in faecal pellets, is ubiquitously distributed 
in/on carpets, mattresses, pillows and other beddings in a suitable 
environment. Dermatophagoides pteronyssinus is probably the most 
prevalent and potent indoor allergen that has been linked to asthma, 
bronchial hypersensitivity and allergic rhinitis in many tropical and 
subtropical countries from Europe, US, Central and South America, 
Australia, PapuaNew Guinea, Island ofMauritius [32, 33, 34, 35, 36, 37] to 
the Far East including Japan, Taiwan and Hong Kong [59，85, 86]. 
fc Hong Kong, information on mite sensitisation associated with allergic 
rhinitis is limited. In 1973，Pickering and Gabrial [87] reported a high 
incidence ofskin sensitivity to storage mites in patients with atopic asthma in 
Hong Kong, and the occurance of relatively large number of these mites in 
house dust samples. This was followed by a detailed study [31] on the 
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seasonal variation of D pteronyssinus count and serum specific IgE 
concentration, implicating mite allergy as an important aetiology ofextrinsic 
asthma in Hong Kong. Recently Leung and Tseng (1993) [40] observed that 
74% ofl,062 school children with allergic rhinitis symptoms were skin-test 
positive for D pteronyssinus sensitisation. 
Hong Kong has a tropical climate, with a mean monthly temperature ranging 
from about 15。C in February to about 28。C in July and a mean monthly 
relative humidity from 52% in November to 80% in July, but which usually 
exceeds 80% from April to September. The highest rainfall occurs during 
the summer especially heavy rain due to tropical cyclones. It is also a 
densely populated city with a very high inhabitant density (eg, 5 
persons/room), which ensures ample supplies of desquamated human scales 
on which the mites feed. 
Al l the above conditions favour the propagation in Hong Kong ofhouse dust 
mites, which survive and multiply fastest between 20-30°C ambient 
temperature and 60-85% relative humidity [88]. Presence of mite allergens 
at high concentrations, time length of exposure (beddings during sleeping), 
and instantaneously aqueous solubility of major allergen Derp I on the nasal 
mucosa must have a substantial enhancing effect on sensitisation in 
predisposed individuals when all these concentration, exposure and potency 
factors are compared with other allergens. This explains the greatly 
increased proportion and severity (in terms of markedly elevated specific IgE 
concentrations) of mite sensitisation in patients and some controls resulting 
from continuous exposure to large amounts of such potent allergen. 
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To elaborate further on this most prevalent and severe allergy, mites are not 
common components ofsurface dust but instead grow best in fabrics such as 
mattresses, quilts, pillows, beddings, carpets, upholstered ftimiture, and stuff 
toys [89, 90]. Clearly, these substances form major foci of infestation. 
Pickering and Gabriel suggested that quilts used by Chinese patients were an 
important source of allergen [87]. This was further confirmed by Gabriel et 
al [31] who studied the seasonal variation of mite counts in the quilts ofthese 
patients. When we consider the limited dwelling area in Hong Kong, quilts 
are usually removed and stored in cabinets during the hot, humid summer 
months, at a time when temperature, relative humidity and rainfall rate are at 
their highest, thereby providing optimal conditions for mite multiplication 
and enabling infestation to spread from one quilt to another. It is interesting 
that our patients and controls were recruited from October and November 
1994, which was the beginning of a Hong Kong winter when quilts were put 
back on the beds. This should also be a period when symptoms of allergic 
rhinitis began or worsened to warrant ENT specialist referral, and blood 
samples were taken for serum total and specific IgE assays. The patients' 
high specific IgE repsonse to mite allergens (mean 43 kUfL) was also 
agreeable with the study by Gabriel [31]. It showed that the monthly dust 
mite specific IgE antibodies ofthe allergic patients changed with a seasonal 
variation that peaked at January, thus suggesting a high level of allergen 
exposure in winter time when quilts were commonly used. 
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7.4,3 Cockroach 
Cockroach has been shown to be an important source of allergen, 
particularly in the inner city dwellings [91，92]. to a survey form Boston, 82 
(41%) of 200 children with asthma or rhinitis or both had cockroach 
sensitisation, indicating the high prevalence of home infestation [93]. 
Cockroaches are seldom seen during daylight hours, they may enter homes 
through cracks in walls or doorways and through the sewer system. They are 
also found in the warehouse of food producing factories, and eggs may be 
carried into homes when cartons and boxes are brought indoors. Li domestic 
dwellings the preferred habitats of cockroach are the kitchen (because of 
food particles), basement and bathroom (because of moisture). Again, 
owing to the crowded living condition in Hong Kong, some ofthe patients 
may live in a public housing estate where they may use the same room for 
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eating and sleeping, and some also for cooking. This is a factor which 
probably accounts for the high prevalence of cockroach sensitisation in 
allergic rhinitis patients in Hong Kong. 
7,4.4 Cat andDog 
Sensitisation to animal allergens can be an important cause of allergic 
rhinitis [94]. This is both because many of these allergens are highly 
immunogenic and because patients insist on having close contact with 
animals. Cat and dog allergens have been found in most household dust 
[95]. They are commonly present in secretions such as saliva, sebaceous 
glands of skin, dander and urine. It is presumed that these soluble allergens 
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dried on fur, beddings, carpets and other domestic objects and become 
airborne when their reservoirs are disturbed. Airbome cat allergens have 
been demonstrated to be associated with particles less than 5 |im in diameter 
[96]. Particles ofthese sizes tend to remain airbome for hours after they are 
produced, to addition, cat allergens are also "sticky" adhering to walls, 
clothings and other surfaces [97]. As a consequence, exposure to cat 
allergens is a prevalent phenomenon even in homes where such animal has 
not been kept [98]. 
We have chosen to test only for specific IgE vs cat and dog because there is 
little farming (involving horse and cow) in Hong Kong, and other animal 
pets are rarely kept. Considering the above properties of cat and dog 
allergens, it is not surprising that some (14%) of our allergic rhinitis patients, 
who belong to a genetically predisposed population to allergy, have acquired 
a mild degree of sensitisation to cat allergens from limited exposure. This 
results in an increased proportion of positive specific IgE test vs cat 
• compared to controls with antibody concentrations not sufficiently elevated 
to show any statistical difference. Our finding that only 2 patients and no 
controls were sensitised to dog dander concurs with the fact that dogs are 
seldom kept in small high-rise residential apartments in Hong Kong. 
Z4.5 Pollens 
Li Hong Kong, documentation of pollinosis is lacking and it is generally 
taken that under the crowded living conditions with few grasslands and trees 
in residential areas, pollen allergy is uncommon [99]. However, a small 
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number ofour patients (15.8%) showed detectable specific IgE antibodies to 
the pollen ofBermuda grass. But the proportion of affected patients and their 
corresponding specified IgE concentrations were not significantly different 
from the control group. There was also no significant difference in the 
proportion ofpositive tests and specific IgE concentrations vs other common 
local pollens studied. (Timonthy grass, ragweed and mugwort; Tables 5.2 
and 5.3). 
The association between sensitisation to Bermuda grass pollen and allergic 
rhinitis can be explained by the fact that our patients usually have multiple 
allergies to environmental inhalent allergens. This is exemplified by our 
finding that of the 54 patients with positive Phadiatop mixed aeroallergen 
screening test, 47 of them (87.0%) had multiple inhalent allergy with 
positive specific IgE tests to at least 2 allergens (see Section 5.2.5). These 
patients were, therefore, atopic by definition and some of them were 
susceptable to pollen sensitisation. 
7,4.6 Moulds 
Mialation of airbome moulds is known to cause both asthma and allergic 
rhinitis [100]. Although an enormous number of fungal species exist and 
their spore concentrations far exceed those of pollens, mould-induced 
allergic respiratory diseases are not well understood [101]. This may be 
attributed partly to the poor knowledge and identification of major allergens 
for most fungal species. These constraints have made the preparation of 
reliable mould extracts for diagnostic use difficult and mould 
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hypersensitivity remains one of the most confusing area in clinical allergy 
[ io i ] . 
A recent study of allergic diseases in Hong Kong showed that 40.6% of 
atopic children had skin sensitivity to house moulds [40]. However, our 
finding was discordent with this report in that there was no significant 
difference in the proportion of mould sensitisation and specific IgE 
concentrations in our allergic rhinitis patients compared to controls (10.5 vs 
3.50/0, 0.09 ±0.04 vs 0.04 ±0.01 kU/L; Table 5.2 and 5.3). 
]n our study, our specific IgE reagent for mould mixture contained 4 
commonest outdoor {Altemaria and Cladosporium) and indoor {Aspergillus 
and Penicillium) fungi. These were different from Leung's in vivo skin 
testing using a mixed extract of Aspergillus, Penicillium, Altemaria and 
Hormodendrum. The disagreement between the two findings could be 
related to genus or species differences in the mould mixture and skin test 
extract in which major allergens have not been clearly standardised. This 
interpretation will have to be confirmed by more exhaustive studies of 
individual mould allergenicity and cross reactivity. However, another 
possibly important reason for a higher rate of skin sensitivity than positive 
serum IgE test may be related to the poorly characterised mould allergen 
extract that may contain irritants inducing false-positive reactions which can 
be further exacerbated by the inclusion of preservatives in the extract that 
also cause irratability [102]. 
1 1 4 
7A.7 Summary 
As established throughout this thesis, in genetical predisposed individuals 
there is a clear relationship between allergen exposure, sensitisation and 
development ofallergic rhinitis, the most prevalent allergic disease in Hong 
Kong. House dust mite and cockroach are ubiquitous in Hong Kong and 
have been identified in this study as the 2 most important sensitising 
allergens of allergic rhinitis. 
In view ofthe significance and prevalence of mite allergen sensitisation, the 
first line of management should be directed towards avoidance of allergen 
exposure (eg, Table 7.1). The aims of such measures are threefold: (1) 
eradication or reduction ofmite population, (2) removal ofallergens, and (3) 
prevention of mite recolonisation. As shown on Table 7.1，the current 
available methods can be by either physical and acaricidal means or both. 
The second level of therapy involves intra-nasal antihistamine and/or 
corticosteroid, together with administration of other symptomatic relief as 
appropriate. Lastly, consideration should be given to specific 
immunotherapy (hyposensitisation) in selected individuals not improved by 
the first two approaches. 
Cockroach eradication by organophosphate and carbamates are most 
commonly used. Eradication requires at least two applications ofchemicals 
because eggs are not affected by the first application. The second 
application should be timed to eliminate the newly hatched insects before 
they become fertile. After eradication, cockroach debris should be removed 
for eliminating the antigenic load. 
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hi general，a good home environment is essential to reduce indoor allergen 
exposure. The importance of a non-smoking environment free of noxious 
irritants should be addressed too. 
House dust mite and cockroach are ubiquitous in Hong Kong. Their 
identification as aetiological agents of allergic rhinitis should certainly help 
the development of strategies for reducing the inhalent allergen load to 
prevent and control of this prevalent and costly health problem in our 
community. * 
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Table7.1 Environmental control of house dust mite sensitisation 
(Adapted from Wood R. Allergens. L i : Allergic and Non-allergic Rhinitis : 
Clinical aspects. Mygind N and Naclerio RM, eds. Copenhagan, 
Munksgaard, 1993 : p.27). 
1 • Encase mattress, box spring, and pillows with plastic covers. 
2. Remove carpets (especially in bedroom and basement). 
3. Remove upholstered fumiture • 
4. Vacuum any remaining carpets and upholstered fumiture weekly. 
5. Hot wash bed linens every 1 - 2 weeks (〉130。F or >55X). 
6. Control humidity (relative humidity <50%) 
-Limit humidifier use 
-Use dehumidifiers i f necessary 
-Increase ventilation (if indoor humidity > outdoor humidity). 
7. Remove stuffed animals, soft toys, curtains. 
8. Consider acaricides and tannic acid sprays. 
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